US20020077593A1 - Apparatus and method for isolated lung access - Google Patents
Apparatus and method for isolated lung access Download PDFInfo
- Publication number
- US20020077593A1 US20020077593A1 US10/074,861 US7486102A US2002077593A1 US 20020077593 A1 US20020077593 A1 US 20020077593A1 US 7486102 A US7486102 A US 7486102A US 2002077593 A1 US2002077593 A1 US 2002077593A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- isolation
- lumen
- inner catheter
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/77—Suction-irrigation systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/85—Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0402—Special features for tracheal tubes not otherwise provided for
- A61M16/0404—Special features for tracheal tubes not otherwise provided for with means for selective or partial lung respiration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0434—Cuffs
- A61M16/0454—Redundant cuffs
- A61M16/0459—Redundant cuffs one cuff behind another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0463—Tracheal tubes combined with suction tubes, catheters or the like; Outside connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0475—Tracheal tubes having openings in the tube
- A61M16/0477—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
- A61M16/0479—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids above the cuff, e.g. giving access to the upper trachea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0475—Tracheal tubes having openings in the tube
- A61M16/0477—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
- A61M16/0484—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids at the distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0486—Multi-lumen tracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M2025/0034—Multi-lumen catheters with stationary elements characterized by elements which are assembled, connected or fused, e.g. splittable tubes, outer sheaths creating lumina or separate cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M2025/0036—Multi-lumen catheters with stationary elements with more than four lumina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/587—Lighting arrangements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1025—Respiratory system
- A61M2210/1039—Lungs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/0032—Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
Definitions
- the present invention relates generally to medical apparatus, systems, methods, and kits. More particularly, the present invention relates to methods and apparatus for isolating sub-bronchial regions of the lung and delivering or retrieving substances from such isolated regions.
- Lung access and isolation is of interest in numerous therapeutic and diagnostic medical procedures.
- access to the lungs is useful for both local and systemic drug delivery, lung lavage, visual assessment and diagnosis of lung function, and the like.
- an endotracheal or tracheostomy tube having an inflatable cuff at its distal end may be placed in a patient's trachea and used to deliver a drug aerosol to the whole of the lungs. While this can improve the efficiency of drug delivery (reducing the amount of drug deposited in the nasal passages or throat), it helps little in targeting treatment within any particular region of the lungs. Thus, it has been further proposed to use a secondary catheter placed through an endotracheal or tracheostomy tube for selectively isolating the left or right bronchus.
- the secondary catheter can have an inflatable cuff which is positioned immediately beyond the main branching between the left and right bronchi.
- One of the bronchi can then be accessed through the secondary catheter while the other is accessed through the tracheal tube.
- Such systems are described, for example, in U.S. Pat. Nos. 5,285,778 and 5,660,175. While such systems offer significant benefits over the use of an endotracheal tube by itself, they still do not permit isolation of sub-bronchial regions of the lung for drug delivery, lavage, or any other purpose.
- a system for bronchoalveolar lavage which can isolate a sub-bronchial region of the lung is described in published Application No. WO 92/10971.
- a co-axial catheter system is placed through an endotracheal tube, with the inner most catheter having an isolation wedge or balloon which can be positioned in a remote bronchiole to effect isolation of a distal region of the lung.
- the outer catheter has no capability for isolating the lung and is used, for example, for ventilating the lung proximal to the isolation cuff. While potentially an improvement over prior systems, the apparatus of WO 92/10971 will be very difficult to position, making targeting of particular sub-bronchial regions very difficult.
- the inability to isolate a bronchus upstream from the distal isolation cuff limits the ability to selectively treat different regions of the bronchus in different ways. That is, while the particular sub-bronchial region which is isolated by the distal isolation cuff may be treated in one way, the remainder of that bronchus as well as the entire other lung must be ventilated and treated in a common manner through either the endotracheal tube or the outer catheter of the co-axial catheter pair.
- the present invention should provide for the efficient delivery of pharmaceutical and other substances to the targeted sub-lobar regions of the lung. Moreover, in some embodiments, the present invention should be able to provide at least a second level of isolation within a particular bronchus and/or the ability to instill the pharmaceuticals or other substances at a point significantly distal to a point of isolation within the bronchus.
- the systems and apparatus of the present invention should be capable of being positioned precisely to a targeted bronchi within the bronchus, preferably providing on-board visualization while components of the system are positioned over a guidewire.
- the apparatus, systems, methods, and kits of the present invention should be suitable for a wide variety of purposes, including pharmaceutical drug delivery, lung lavage (optionally in combination with drug delivery), diagnosis (optionally in combination with lung lavage), and the like.
- the present invention should be useful for localized drug delivery where a particular drug or other therapeutic agent can be delivered to a well-defined, isolated sub-bronchial region of the lung (as defined hereinafter) with little or no delivery to other regions of the lung. At least some of these objectives will be met by the inventions described hereinafter.
- WO 92/10971 describes a bronchoalveolar lavage catheter system having an outer catheter and an inner catheter with an enlarged (optionally inflatable) tip which is advanced until the tip wedges in a bronchiole of the patient. A region of the lungs distal to the enlarged tip may then be lavaged to retrieve sample.
- U.S. Pat. Nos. 5,660,175; 5,653,231; 4,716,896; and 4,453,545, describe single and co-axial catheter systems for accessing a patient's lungs.
- U.S. Pat. No. 5,285,778, describes a co-axial endoscopic lung access system.
- U.S. Pat. Nos. 5,309,903 and 5,207,220 describe systems for administering liquid pharmaceutical formulations to an isolated lung.
- the present invention provides improved apparatus, systems, methods, and kits for isolating lobar and sub-lobar regions of a patient's lungs.
- the isolated region will be a portion (not the whole) of the right or left lung, and isolation will be accomplished by occluding a bronchial passage at at least one location in the lobar, segmental, and subsegmental bronchus.
- a primary occlusion will be formed after both the main bifurcation of the trachea and a further bifurcation into the lobar bronchus.
- the lobar and/or sub-lobar region can be further isolated at at least one secondary location distal to the primary point of isolation and usually after further branching of the bronchial passages. Isolation at the primary location and optional additional locations within the bronchial passages will usually be effected by expansion of an occlusion member, such as an inflatable cuff, inflatable balloon, or the like.
- lobar or sub-lobar region Once the lobar or sub-lobar region has been isolated, a variety of therapeutic and diagnostic procedures can be performed within the isolated region. For example, pharmaceutical formulations including small molecule drugs, biological macromolecular drugs, and the like, can be specifically delivered to the isolated region with minimal or no cross-delivery to other regions of the lungs. Similarly, lavage may be performed within the isolated region with minimal impact on adjacent regions of the lungs. Isolation of the lobar or sub-lobar region permits such drug delivery and lavage procedures to be further controlled by control of the volumes, rates, pressures, temperatures, repetitions, retention times, and other method and system parameters. For example, the pressure within the isolated region can be controlled separately from the pressure or pressures maintained outside of the isolated region.
- the isolated lobar or sub-lobar region will be expanded which may, in some cases, enhance delivery of a drug or permit more efficient lavage of the region.
- the risk of migration of toxic therapeutic or other agents away from the isolated region can be greatly reduced.
- an isolation catheter comprises a catheter body having a proximal end, a distal end, and a main lumen therebetween.
- An expansible occlusion member is disposed at or near the distal end of the catheter body, and optical and illumination fibers are disposed in the catheter body to permit imaging of a region distal to the distal end of the catheter body when the catheter is in use.
- a hub will be attached to the proximal end of the catheter and include at least one connection port for the main lumen of the catheter.
- the hub will contain a second connection port for the optical and illumination fibers, and may contain further connection ports for other lumens and capabilities of the catheter, as described hereinafter.
- the catheter body of the isolation catheter will be adapted and sized to allow advancement of the distal end of the catheter body to a target bronchial passage within the lung which is located distal to a first branching of the right or left main stem bronchus.
- a distal region of the catheter body will have an outer diameter which is sufficiently small and flexible to be advanced into bronchioles having a diameter below about 12 mm, preferably below about 10 mm, and often below about 8 mm.
- Exemplary catheter bodies will have a length in the range from 40 cm to 150 cm, preferably from 50 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm, preferably from 3 mm to 6 mm, and a main lumen diameter in the range from 1 mm to 6 mm, preferably from 2 mm to 4 mm.
- the expansible occlusion member will typically be an inflatable cuff or balloon having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.
- the catheter body will include at least one additional lumen for inflation of the inflatable cuff, and the additional lumen will be connected to an additional connector port on the catheter hub. Further optionally, the catheter body may include an additional lumen disposed to direct a washing fluid over a distal tip of the optical fiber which terminates at or near the distal end of the catheter body.
- systems according to the present invention comprises an isolation catheter as described above combined with an inner catheter to form a lung infusion/aspiration system.
- the inner catheter has a proximal end, a distal end, and a central lumen extending between the proximal end and distal end.
- the inner catheter is positionable within the main lumen of the isolation catheter so that the catheters may be used together in a co-axial fashion and further so that an annular lumen is formed within the main lumen of the isolation catheter, i.e., between an inner surface of the main lumen of the isolation catheter and an outer surface of the inner catheter.
- the connector port on the isolation catheter has an additional connector port for the annular lumen.
- the system may comprise an adapter connectable to the hub on the isolation catheter, where the adapter has a connector port for the annular lumen.
- the dimensions and physical characteristics of the inner catheter will be chosen to permit introduction through the main lumen of the isolation catheter and further to permit advancement of the inner catheter beyond the distal end of the isolation catheter into bronchial passages or bronchioles distal to the isolation catheter when in use.
- An exemplary inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, preferably from 1.5 mm to 3.5 mm, an inner lumen diameter in the range from 0.1 mm to 3.5 mm, preferably from 1 mm to 3 mm, and a length which is at least 10 cm longer than the isolation catheter in the system.
- the inner catheter will have a length in the range from 50 cm to 200 cm, preferably from 60 cm to 110 cm.
- the inner catheter may have an expansible occlusion member disposed near its distal end to permit selective isolation of a lobar or sub-lobar region between proximal and distal points along the bronchial passages of the lung.
- the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.
- the inner catheter When including an inflatable cuff, the inner catheter will usually further comprise an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff. Moreover, when provided with an inflatable cuff, the inner catheter will usually comprise an infusion/aspiration lumen having a distal port position proximally of the inflatable cuff so that substances, washing fluids, or the like, may be delivered or aspirated through the lumen between the inflatable cuff on the isolation catheter and the inflatable cuff on the inner catheter. Still further optionally, the inner catheter may comprise a vibratory element, such as an ultrasonic transducer, near its distal end to assist in dissolution of occlusive materials, enhance drug uptake, or the like.
- a vibratory element such as an ultrasonic transducer
- the inner catheter may comprise two or more lumens, where at least two of the lumens are joined near a distal end to permit mixing of two or more gas or liquid streams which are being delivered through the catheter. The mixed streams are then released through a common outlet port on the inner catheter.
- the two streams may be delivered in parallel from the distal tip of the inner catheter for a variety of purposes.
- the systems of the present invention may comprise further elements, such as guidewires, tracheal tubes with integral visualization (including both endotracheal and tracheostomy tubes), therapeutic or diagnostic reagents, and/or other system components intended to cooperate in performing the methods of the present invention as described in more detail below.
- the systems of the present invention may be incorporated into kits where one or more system components are packaged together with instructions for use setting forth the methods described in more detail below. Such kits will usually further comprise packages for holding the system component(s) together with the instructions for use.
- Methods according to the present invention comprise using an isolation catheter and an inner catheter (generally as described above) for isolating a lobar or sub-lobar region of the lung and then performing a procedure within the isolated region.
- the methods are used for delivering a substance, typically a drug or other pharmaceutically active substance, to the isolated region.
- the methods are used for ravaging the isolated region, i.e., introducing and removing a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like, to the region.
- a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like
- the lavage and substance delivery methods can be combined where a drug or other active agent is included in the washing liquid which is being used for lavage.
- the methods of the present invention comprise positioning a distal end of the isolation catheter within a bronchial passage beyond a first branching within the right or left lung.
- the inner catheter is then positioned through the main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchial passage distally beyond the distal end of the isolation catheter.
- At least one occlusion element near the distal end of the isolation catheter is expanded within the bronchial passage to isolate a target lobar or sub-lobar region. Thereafter, in the case of drug or other substance delivery, the substance may be delivered through the inner catheter to the isolated region of the lung.
- the washing liquid may be infused through either (or both) of the inner catheter or the isolation catheter and aspirated through the other (or both) of the two catheters. Infusion and aspiration may be performed sequentially or concurrently, or in combinations of both sequential and concurrent infusion and aspiration. Often, it will be preferred to infuse the washing liquid through the inner catheter so that it enters the isolated region generally in a distal portion thereof and diffuses or migrates back toward the isolation catheter where it is collected and removed. In some instances, the washing liquid drug, or other substance may be introduced as a bolus and held or retained within the isolated sub-lobar region for a pre-selected retention time prior to initiating aspiration.
- the washing liquid may comprise a drug or other biologically active substance to perform a therapeutic action while the region is being ravaged.
- the substance may comprise any one of a wide variety of pharmaceutical agents, including small molecule drugs, protein drugs, carbohydrate drugs, nucleic acid drugs (genes, optionally in combination with delivery vectors and/or expression control segments), and the like.
- the delivered substances may be in the form of an aerosol, optionally produced within the inner catheter or prior to introduction to the inner catheter.
- the substance may comprise a liquid which is instilled through the inner catheter.
- it will frequently be preferred to position the isolation catheter and inner catheter through a visualizing endotracheal or tracheostomy tube which has been previously placed in the patient's trachea.
- Suitable visualizing endotracheal tubes are described, for example, in U.S. Pat. No. 5,285,778, the full disclosure of which is incorporated herein by reference.
- a visualizing endotracheal or tracheostomy tube will include an inflatable cuff or other occlusion element so that the whole lungs may be isolated from the upper regions of the trachea. In this way, the patient may be ventilated through the tracheal tube while other regions of the lung are isolated.
- direct visualization at the bifurcation between the left and right lungs helps position in place the isolation catheter to the target region to be isolated.
- the regions of the lung above or proximal to the occlusion element on the isolation catheter may be ventilated and maintained at a different pressure through the tracheal tube.
- the isolation catheter, and the inner catheter at least three isolated zones within the lung may be maintained with different pressures being simultaneously maintained.
- different substances can be delivered to each of these regions through the lumens of the inner catheter, isolation catheter, and the tracheal tube, respectively.
- pressure within the isolated region may be maintained higher than that within the proximal regions of the lung (where pressure is being controlled through the tracheal tube) resulting in expansion of the isolated region which may be beneficial for a variety of reasons.
- pressure within the isolated region may be maintained below that of the proximal portions of the lung, reducing the risk of release of materials from the isolated region into the proximal portions of the lung.
- a third distal region of the lung may be pressurized separately from the intermediate and proximal regions.
- the isolation catheter and/or inner catheter will preferably be performed over a guidewire.
- the guidewire will first be introduced to a point beyond the location in a bronchial passage where it is desired to position a distal end of the isolation catheter and/or inner catheter.
- the isolation catheter will comprise optical and illumination fibers which permit direct visual observation of the guidewire as the guidewire and isolation catheter are advanced.
- the guidewire and isolation catheter can be advanced in tandem so that, as successive bifurcations are approached, the physician can steer a curved end of the guidewire into the desired branch bronchial passage.
- an occlusion cuff may be expanded and the inner catheter optionally introduced over the guidewire or introduced directly through the main lumen of the isolation catheter without a guidewire. While the inner catheter may in some instances incorporate optical and illumination fibers, it will usually not have such imaging capabilities. Thus, positioning of the inner catheter will frequently be done solely by observation from the isolation catheter and/or under fluoroscopic or other external imaging. Of course, positioning of an isolation catheter can also be performed solely under fluoroscopic imaging (or in combination with both direct visual and fluoroscopic imaging), particularly when the isolation catheter does not include imaging capability.
- the inner catheter may be moved and repositioned within the bronchial passages of the isolated region to deliver a substance or release a washing fluid for lavage at different points within the region.
- the inner catheter can be moved (i.e., advanced distally or drawn proximally) while the substance or washing liquid is being released in order to better distribute the material within the isolated region.
- the inner catheter could also be moved through the isolated region in order to aspirate materials which have been introduced, either alone or in combination with aspiration through the main lumen of the isolation catheter.
- Kits according to the present invention include at least an isolation catheter, and optionally include an inner catheter, a tracheal tube, and/or a guidewire. Other components including medical and bioactive reagents, e.g., drugs, washing liquids, or the like, may also be provided within the kits.
- the kits will comprise instructions for use setting forth a method of the present invention as generally set forth above.
- the kits will usually be packaged together in conventional medical packaging, such as a pouch, tray, tube, box, bag, or the like. Instructions for use may be provided on a separate printed sheet, or may printed in whole or in part on the packaging materials. When printed separately, the instructions are commonly referred to as a package insert.
- at least the isolation catheter and other components of the kit which would be used in the procedure will be packaged in a sterile manner within the kit.
- FIG. 1 is a side view of a sub-lobar isolation catheter constructed in accordance with the principles of the present invention.
- FIG. 1A is a cross-sectional view taken along line 1 A- 1 A in FIG. 1.
- FIG. 1B is an alternative cross-sectional view similar to that shown in FIG. 1A.
- FIG. 2 is a side view of a first alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
- FIG. 2A is a cross-sectional view taken along line 2 A- 2 A of FIG. 2.
- FIG. 3 is a side view of a second alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
- FIG. 3A is a cross-sectional view taken along line 3 A- 3 A of FIG. 3.
- FIG. 4 illustrates a system comprising a sub-lobar isolation catheter and an inner catheter constructed in accordance with the principles of the present invention.
- FIG. 5 is a side view of the inner catheter of FIG. 4 mounted within the sub-lobar isolation catheter, with portions broken away.
- FIG. 6 illustrates a first alternative construction of the inner catheter of the present invention.
- FIG. 6A is a cross-sectional view taken along line 6 A- 6 A of FIG. 6.
- FIG. 7 is a second alternative construction of the inner catheter of the present invention.
- FIG. 7A is a cross-sectional view taken along line 7 A- 7 A of FIG. 7.
- FIG. 8 is a third alternative construction of the inner catheter of the present invention.
- FIG. 8A is a cross-sectional view taken along line 8 A- 8 A of FIG. 8.
- FIG. 8B is a detailed view of the distal end of the catheter of FIG. 8 taken along line 8 B- 8 B of FIG. 8.
- FIG. 9 is a fourth alternative construction of the inner catheter of the present invention.
- FIG. 9A is a cross-sectional view taken along line 9 A- 9 A of FIG. 9.
- FIG. 10 illustrates introduction of a sub-lobar isolation catheter to a diseased region within a lung according to the method of the present invention.
- FIG. 11 is a detailed view of the introduction of FIG. 10 shown with the isolation catheter being passed through a visualizing endotracheal tube.
- FIGS. 12 A- 12 C illustrate use of the various inner catheters for performing particular procedures in accordance with the principles of the present invention.
- FIG. 13 illustrates a kit constructed in accordance with the principles of the present invention.
- Isolation of a lobar or sub-lobar region of the lung is accomplished by occluding a lumen of a bronchial passage (bronchiole) at a location distal to a first branch in the network of bronchial passages within the right or left lung.
- Substances may be delivered to and/or a washing fluid may be used to lavage the isolated lobar or sub-lobar region of the lung by introducing or exchanging materials through a lumen of an isolation catheter, usually in combination with delivery or exchange through a lumen of an associated inner catheter.
- An inflatable cuff or other expansible isolation element on the isolation catheter is positioned at an isolation location within the bronchial passage, and the cuff inflated.
- the inner catheter is then positioned at a desired location distal to the end of the isolation catheter, and the isolated region is thus accessible through at least two access lumens, i.e., one lumen through the inner catheter and a second annular lumen between the exterior of the inner catheter and the interior luminal wall of the isolation catheter.
- access lumens may be used separately or in combination in a variety of ways to perform the methods of the present invention.
- an isolation catheter 10 comprises a catheter body 12 having a proximal end 16 and a distal end 14 .
- An inflatable isolation cuff 18 is disposed near the distal end 14 of the catheter body 12 , and an inflation lumen 20 extends through the catheter body from a proximal port 22 on proximal hub 24 to the balloon 18 .
- the catheter 10 further comprises an optical fiber or bundle 24 and an illumination fiber or bundle 26 , both of which are brought out to a suitable connector 28 through a connecting cable 30 .
- the optical fiber 24 and illuminating fiber 26 may be plugged into a variety of conventional imaging consoles which can provide a real time, visual image looking forwardly from the distal end 14 of the catheter body 12 .
- the catheter body 12 further includes a main lumen 32 which extends the entire length of the catheter body and passes through connector hub 36 to proximal connector 34 .
- the main lumen 32 can be used for introducing and/or aspirating materials which are introduced to or withdrawn from an isolated lobar or sub-lobar region of the lung.
- the main lumen 32 will receive an inner catheter (FIGS. 4 and 5 below), and the isolation catheter and inner catheter will be utilized together for delivering, collecting, and removing materials from an isolated sub-lobar region of the lung.
- the catheter body 12 of the isolation catheter 10 is a single extrusion having four lumens or passages formed therein. Two of the lumens form the inflation lumen 20 and the main lumen 32 , while the other two lumens house the optical fiber bundle 24 and the illumination fiber bundle 26 .
- the catheter body 12 could also be formed from a plurality of separate tubular members which are held together by an outer cover, as illustrated in FIG. 11B.
- an inner tube 40 can be disposed in parallel with the optical fiber bundle 24 and the illuminating fiber bundle 26 .
- a separate tubular member 42 can also be placed co-axially on the exterior of tube 40 , and all of the components held together by a cover 44 which may, for example, be shrink-wrapped over the assembly.
- An inflation lumen 46 is then provided in the space under the cover 44 which is unoccupied by the optical and tubular components.
- a variety of other specific construction designs may also be provided.
- the catheter body 12 may be formed from conventional materials, such as polyamides (nylons), polyethylenes, polyurethanes, polytetrafluoroethylenes (PTFEs), polyimides, and the like.
- the inflatable cuff can be formed from other conventional materials, such as polyvinylchloride, polyurethanes, high density polyethylenes, low density polyethylenes, nylons, PTFEs, and the like. Exemplary and preferred dimensions for the catheter body 12 of the isolation catheter 10 have been set forth above.
- FIGS. 2 and 2A A second exemplary isolation catheter 50 constructed in accordance with the principles of the present invention is illustrated in FIGS. 2 and 2A.
- the construction of isolation catheter 50 is generally the same as that for isolation catheter 10 , and like components will be given like numbers.
- catheter 50 includes a lens washing lumen 52 which extends from lens washing port 54 in the hub 56 to a position at the distal tip of the catheter body which lies immediately over a lens (not shown) formed at the distal end of the optical fiber or bundle 26 . Because of the humid and contaminating nature of the lungs, it will be a significant benefit to be able to wash the optical viewing lens whenever the lens becomes obscured to do condensation or fouling.
- FIGS. 3 and 3A A third exemplary construction of the isolation catheter of the present invention is illustrated in FIGS. 3 and 3A.
- an isolation catheter 60 comprises generally the same components as catheters 10 and 50 , except that catheter body 12 further includes a lumen 62 which receives a guidewire (or alternatively an articulating steering mechanism) and which extends from port 64 on hub 66 to the distal end 14 of the catheter body 12 .
- a guidewire or alternatively an articulating steering mechanism
- isolation catheter 60 is specially adapted for introduction over a guidewire (or other steering mechanism) according to the methods of the present invention and as described in more detail below.
- the isolation catheter 60 can also include a vibratory element 66 near its distal end.
- the vibratory element could be a mechanically driven surface, but will usually comprise an ultrasonic transducer intended to deliver vibratory energy to disrupt blockages in the bronchus, enhance drug delivery, or the like.
- Systems 70 according to the present invention comprise an isolation catheter 10 (or any of the other isolation catheters described above or which would come within the principles of the present invention) and an inner catheter 80 .
- the inner catheter 80 is sized and adapted to fit within the main lumen 32 of the isolation catheter 10 .
- the inner catheter 80 has a distal end 82 and a proximal end 84 which terminates in a connecting hub 86 .
- the isolation catheter 10 includes a hub 96 which is similar to the previously described hubs, except that a proximal end has been modified to slidably receive the inner catheter 80 .
- an O-ring 90 is provided to provide a sliding pneumatic or hydraulic seal about the inner catheter.
- an access port 92 is provided in the hub 96 to permit communication with the annular lumen 94 disposed between the exterior of inner catheter 80 and the interior of the main lumen 32 of the isolation catheter 10 .
- materials can be withdrawn or introduced through the isolation catheter 10 as well as through the lumen of the inner catheter 80 . More particularly, it permits two spaced-apart access points, i.e., at the distal ends of the isolation catheter 10 and inner catheter 80 , respectively, to be established within an isolated lobar or sub-lobar region of the lungs. Using two access points, a variety of substance delivery and lavage protocols can be run, as described in more detail below.
- Inner catheter 100 includes catheter body 102 having an inflatable isolation cuff 104 near its distal end.
- a plurality of infusion/aspiration ports 106 are also formed near the distal end 103 of the catheter body 102 and are connected by a lumen 108 to an aspiration/infusion port 110 in proximal hub 112 .
- the inflatable cuff 104 may be inflated by connecting a suitable inflation source to connector 114 which delivers the inflation medium through lumen 116 to the cuff 104 .
- a central lumen 120 extends the length of the catheter body from its distal end 103 to a connection port 122 in the hub 112 .
- infusion/aspiration ports 106 proximal to the inflatable cuff 104 , it will be appreciated that substances may be delivered or removed from a region which is proximal to the cuff 104 but distal to the isolation cuff on the isolation catheter with which the inner catheter 100 is used.
- FIGS. 7 and 7A Yet a further alternative embodiment of an inner catheter 130 is illustrated in FIGS. 7 and 7A.
- the inner catheter 130 includes an ultrasonic or other vibratory element 132 (shown in broken line) at or near its distal end 134 .
- the ultrasonic element 132 may be positioned at the distal end of a lumen 136 which extends through the length of the catheter 130 .
- the lumen 136 may thus hold wires necessary to power the ultrasonic transducer, where the wires are brought out through a connecting cable 140 and terminate in a plug 142 .
- An aspiration/infusion lumen 150 also extends the length of the catheter 130 and terminates in a luer or other connector 152 at the proximal end of the catheter.
- a similar ultrasonic or other vibratory element may be disposed on the isolation catheter, either in addition to or in place of the vibration element 132 on the inner catheter.
- the vibratory element 66 may also be placed distal to the cuff to deliver energy into an isolated region.
- the catheter 160 comprises a catheter body 162 having a distal end 164 and a proximal end 166 .
- a pair of lumens 168 and 170 extend the length of the catheter body 162 from ports 172 and 174 , respectively, and proximal hub of 176 to each of the lumens 168 and 170 is suitable for delivering a material, either liquid, aerosol, or solid (in some flowable form), from the ports 172 and 174 to a mixing region 180 near a distal instillation port 182 at a distal tip of the catheter.
- air or other gas may be delivered through the larger lumen 170 so that it flows the mixing area 180 .
- the airflow can act as a Venturi in suspending an aerosolizing material which is delivered to the mixing area.
- droplets or particulates can be delivered or instilled directly within an isolated lobar or sub-lobar region of the lung.
- the particulate or droplet size i.e., to arrange generally between 0.1 ⁇ m to 5 ⁇ m
- absorption of these materials into the alveolar regions of the lungs can be enhanced.
- the particulate or droplet size outside this range, usually above 5 ⁇ m, preferably above 10 ⁇ m, local delivery (i.e., not systemically absorbed) of a drug or other substance can be achieved.
- the inner catheter 200 comprises a catheter body 202 having a distal end 204 and a proximal end 206 .
- the catheter body includes a central lumen 210 and a pair of instillation lumens 212 and 214 .
- the catheter would be suitable for aerosolization of substances, particularly by delivering a liquid or solid powder substance through one of the lumens 212 and air or other aerosolization gas through the other lumen 214 .
- the central lumen 210 could be used for aspiration, delivery of other drug materials, or the like.
- an isolation catheter 10 may be introduced through the mouth, the trachea T and into a lobe L of the lung until it reaches a diseased region DR.
- the isolation catheter 10 could be introduced through an incision in the neck, usually through a tracheostomy tube.
- cuff 18 may be inflated to isolate regions of the lung distal to the inflated cuff in the bronchial passage. As illustrated in FIG.
- catheter 10 may optionally be delivered through a visualizing endotracheal tube VETT (or visualizing tracheostomy tube), where a cuff C on the tube is inflated within the trachea T at a region just above the main lung bifurcation into the right and left lungs RL and LL.
- the isolation catheter 10 may be advanced over a guidewire GW, where visualization of the guidewire immediately ahead of the catheter may be observed on the video screen V attached to the optical and illumination fibers within the catheter 10 .
- the guidewire may be advanced just ahead of the distal end of the catheter 10 in tandem so that the guidewire can be observed as it is rotated and introduced selectively into the bronchial passages at bifurcations.
- advancement of the catheter 10 may be observed fluoroscopically or using any other available external imaging systems.
- the inflatable cuff 18 may be inflated to both anchor the distal end of the catheter and isolate regions of the lung distal thereto.
- the inner catheter 80 may be advanced through the main lumen 34 so that the distal end 82 of the inner catheter progresses distally into a desired bronchial passage. Advancement of the distal end 82 may optionally be over a guidewire and will usually be performed under visual imaging using the optical illuminating fibers in the isolation catheter 10 .
- a drug can be delivered through the distal end 82 of the inner catheter to treat a target region TR, shown in broken line in FIG. 12B, additionally or alternatively, the target region TR can be lavaged by introducing a washing fluid through either catheter 10 or 80 and/or collecting the fluid through either of catheter 10 or 80 .
- inner catheter 100 having inflatable cuff 104 at its distal end may be introduced through the isolation catheter 10 .
- a modified target region MTR can be defined.
- the target region MTR in FIG. 12C will be more limited in volume than that formed in FIG. 12B where there is no distal isolation.
- Use of the second isolation cuff 104 on the inner catheter 100 permits much more specifically focused treatment protocols, both drug delivery and lavage, to be performed. By delivering or aspirating the materials through the ports 106 , it will be appreciated that the treatment is substantially limited to between the two cuffs 18 and 104 .
- kits 300 will comprise at least a lobar or sub-lobar isolation catheter 10 and an inner catheter 80 together with instructions for use IFU.
- the kits may further include other system components as described above, such as a visualizing endotracheal tube VET, a guidewire GW, and/or various reagents (not shown).
- the instructions for use IFU will set forth any of the methods as described above, and all kit components will usually be packaged together in a suitable package 350 , such as a pouch, tray, tube, box, bag, or the like.
- kits components such as the isolation catheter 10 and inner catheter 80 , which will be used in performing the procedure on the patient, will be sterilized and maintained sterilely within the kit.
- separate pouches, bags, trays, or other packaging materials may be provided within a larger package, where the smaller packs may be separately opened and will separately maintain the components in a sterile fashion.
Landscapes
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Endoscopes (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.
Description
- This application is a division of application Ser. No. 09/425,272, filed on Oct. 21, 1998, now U.S. Pat. No. ______, the full disclosure of which is incorporated herein by reference.
- 1. Field of the Invention
- The present invention relates generally to medical apparatus, systems, methods, and kits. More particularly, the present invention relates to methods and apparatus for isolating sub-bronchial regions of the lung and delivering or retrieving substances from such isolated regions.
- Lung access and isolation is of interest in numerous therapeutic and diagnostic medical procedures. In particular, access to the lungs is useful for both local and systemic drug delivery, lung lavage, visual assessment and diagnosis of lung function, and the like.
- For drug delivery, access is most simply achieved by introducing an aerosol to the lungs through the mouth or nose, and a variety of inhalers, nebulizers, metered dose inhalers (MDIs), nasal sprayers, and the like, have been developed over the years. While very effective for many drugs, delivery through the mouth or nose can be very inefficient, often with less than 20% of the drug reaching circulation or a targeted local treatment region. Moreover, inhalation through the mouth or nose is not able to target drug delivery to a particular region of the lungs. While this may not be a problem for systemic delivery, it can be a significant drawback in the treatment of localized disease where a highly controlled delivery profile would be preferred.
- In an effort to overcome at least some of these shortcomings, a variety of endotracheal drug delivery and lung lavage systems have been developed. Most simply, an endotracheal or tracheostomy tube having an inflatable cuff at its distal end may be placed in a patient's trachea and used to deliver a drug aerosol to the whole of the lungs. While this can improve the efficiency of drug delivery (reducing the amount of drug deposited in the nasal passages or throat), it helps little in targeting treatment within any particular region of the lungs. Thus, it has been further proposed to use a secondary catheter placed through an endotracheal or tracheostomy tube for selectively isolating the left or right bronchus. For example, the secondary catheter can have an inflatable cuff which is positioned immediately beyond the main branching between the left and right bronchi. One of the bronchi can then be accessed through the secondary catheter while the other is accessed through the tracheal tube. Such systems are described, for example, in U.S. Pat. Nos. 5,285,778 and 5,660,175. While such systems offer significant benefits over the use of an endotracheal tube by itself, they still do not permit isolation of sub-bronchial regions of the lung for drug delivery, lavage, or any other purpose.
- A system for bronchoalveolar lavage which can isolate a sub-bronchial region of the lung is described in published Application No. WO 92/10971. A co-axial catheter system is placed through an endotracheal tube, with the inner most catheter having an isolation wedge or balloon which can be positioned in a remote bronchiole to effect isolation of a distal region of the lung. The outer catheter has no capability for isolating the lung and is used, for example, for ventilating the lung proximal to the isolation cuff. While potentially an improvement over prior systems, the apparatus of
WO 92/10971 will be very difficult to position, making targeting of particular sub-bronchial regions very difficult. Moreover, the inability to isolate a bronchus upstream from the distal isolation cuff limits the ability to selectively treat different regions of the bronchus in different ways. That is, while the particular sub-bronchial region which is isolated by the distal isolation cuff may be treated in one way, the remainder of that bronchus as well as the entire other lung must be ventilated and treated in a common manner through either the endotracheal tube or the outer catheter of the co-axial catheter pair. - For these reasons, it would be desirable to provide improved apparatus, systems, methods, and kits for the treatment and diagnosis of selected regions of a patient's lungs, particularly a lobar or targeted sub-lobar regions of the patient's lungs. The present invention should provide for the efficient delivery of pharmaceutical and other substances to the targeted sub-lobar regions of the lung. Moreover, in some embodiments, the present invention should be able to provide at least a second level of isolation within a particular bronchus and/or the ability to instill the pharmaceuticals or other substances at a point significantly distal to a point of isolation within the bronchus. The systems and apparatus of the present invention should be capable of being positioned precisely to a targeted bronchi within the bronchus, preferably providing on-board visualization while components of the system are positioned over a guidewire. Additionally, the apparatus, systems, methods, and kits of the present invention should be suitable for a wide variety of purposes, including pharmaceutical drug delivery, lung lavage (optionally in combination with drug delivery), diagnosis (optionally in combination with lung lavage), and the like. In particular, the present invention should be useful for localized drug delivery where a particular drug or other therapeutic agent can be delivered to a well-defined, isolated sub-bronchial region of the lung (as defined hereinafter) with little or no delivery to other regions of the lung. At least some of these objectives will be met by the inventions described hereinafter.
- 2. Description of the Background Art
- WO 92/10971 describes a bronchoalveolar lavage catheter system having an outer catheter and an inner catheter with an enlarged (optionally inflatable) tip which is advanced until the tip wedges in a bronchiole of the patient. A region of the lungs distal to the enlarged tip may then be lavaged to retrieve sample. U.S. Pat. Nos. 5,660,175; 5,653,231; 4,716,896; and 4,453,545, describe single and co-axial catheter systems for accessing a patient's lungs. U.S. Pat. No. 5,285,778, describes a co-axial endoscopic lung access system. U.S. Pat. Nos. 5,309,903 and 5,207,220 describe systems for administering liquid pharmaceutical formulations to an isolated lung.
- The present invention provides improved apparatus, systems, methods, and kits for isolating lobar and sub-lobar regions of a patient's lungs. The isolated region will be a portion (not the whole) of the right or left lung, and isolation will be accomplished by occluding a bronchial passage at at least one location in the lobar, segmental, and subsegmental bronchus. Thus, a primary occlusion will be formed after both the main bifurcation of the trachea and a further bifurcation into the lobar bronchus. Optionally, the lobar and/or sub-lobar region can be further isolated at at least one secondary location distal to the primary point of isolation and usually after further branching of the bronchial passages. Isolation at the primary location and optional additional locations within the bronchial passages will usually be effected by expansion of an occlusion member, such as an inflatable cuff, inflatable balloon, or the like.
- Once the lobar or sub-lobar region has been isolated, a variety of therapeutic and diagnostic procedures can be performed within the isolated region. For example, pharmaceutical formulations including small molecule drugs, biological macromolecular drugs, and the like, can be specifically delivered to the isolated region with minimal or no cross-delivery to other regions of the lungs. Similarly, lavage may be performed within the isolated region with minimal impact on adjacent regions of the lungs. Isolation of the lobar or sub-lobar region permits such drug delivery and lavage procedures to be further controlled by control of the volumes, rates, pressures, temperatures, repetitions, retention times, and other method and system parameters. For example, the pressure within the isolated region can be controlled separately from the pressure or pressures maintained outside of the isolated region. In this way, a variety of delivery parameters can be controlled. By elevating pressure within the isolated region above that in the surrounding regions of the lung, the isolated lobar or sub-lobar region will be expanded which may, in some cases, enhance delivery of a drug or permit more efficient lavage of the region. Alternatively, by elevating pressure within the “other” lung regions above that within the isolated region, the risk of migration of toxic therapeutic or other agents away from the isolated region can be greatly reduced.
- According to the present invention, an isolation catheter comprises a catheter body having a proximal end, a distal end, and a main lumen therebetween. An expansible occlusion member is disposed at or near the distal end of the catheter body, and optical and illumination fibers are disposed in the catheter body to permit imaging of a region distal to the distal end of the catheter body when the catheter is in use. Usually, a hub will be attached to the proximal end of the catheter and include at least one connection port for the main lumen of the catheter. Optionally, the hub will contain a second connection port for the optical and illumination fibers, and may contain further connection ports for other lumens and capabilities of the catheter, as described hereinafter.
- The catheter body of the isolation catheter will be adapted and sized to allow advancement of the distal end of the catheter body to a target bronchial passage within the lung which is located distal to a first branching of the right or left main stem bronchus. Usually, at least a distal region of the catheter body will have an outer diameter which is sufficiently small and flexible to be advanced into bronchioles having a diameter below about 12 mm, preferably below about 10 mm, and often below about 8 mm. Exemplary catheter bodies will have a length in the range from 40 cm to 150 cm, preferably from 50 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm, preferably from 3 mm to 6 mm, and a main lumen diameter in the range from 1 mm to 6 mm, preferably from 2 mm to 4 mm. The expansible occlusion member will typically be an inflatable cuff or balloon having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm. Usually, the catheter body will include at least one additional lumen for inflation of the inflatable cuff, and the additional lumen will be connected to an additional connector port on the catheter hub. Further optionally, the catheter body may include an additional lumen disposed to direct a washing fluid over a distal tip of the optical fiber which terminates at or near the distal end of the catheter body.
- In a preferred aspect, systems according to the present invention comprises an isolation catheter as described above combined with an inner catheter to form a lung infusion/aspiration system. The inner catheter has a proximal end, a distal end, and a central lumen extending between the proximal end and distal end. The inner catheter is positionable within the main lumen of the isolation catheter so that the catheters may be used together in a co-axial fashion and further so that an annular lumen is formed within the main lumen of the isolation catheter, i.e., between an inner surface of the main lumen of the isolation catheter and an outer surface of the inner catheter. Optionally, the connector port on the isolation catheter has an additional connector port for the annular lumen. Alternatively, the system may comprise an adapter connectable to the hub on the isolation catheter, where the adapter has a connector port for the annular lumen. The dimensions and physical characteristics of the inner catheter will be chosen to permit introduction through the main lumen of the isolation catheter and further to permit advancement of the inner catheter beyond the distal end of the isolation catheter into bronchial passages or bronchioles distal to the isolation catheter when in use.
- An exemplary inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, preferably from 1.5 mm to 3.5 mm, an inner lumen diameter in the range from 0.1 mm to 3.5 mm, preferably from 1 mm to 3 mm, and a length which is at least 10 cm longer than the isolation catheter in the system. Typically, the inner catheter will have a length in the range from 50 cm to 200 cm, preferably from 60 cm to 110 cm. Optionally, the inner catheter may have an expansible occlusion member disposed near its distal end to permit selective isolation of a lobar or sub-lobar region between proximal and distal points along the bronchial passages of the lung. Typically, the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.
- When including an inflatable cuff, the inner catheter will usually further comprise an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff. Moreover, when provided with an inflatable cuff, the inner catheter will usually comprise an infusion/aspiration lumen having a distal port position proximally of the inflatable cuff so that substances, washing fluids, or the like, may be delivered or aspirated through the lumen between the inflatable cuff on the isolation catheter and the inflatable cuff on the inner catheter. Still further optionally, the inner catheter may comprise a vibratory element, such as an ultrasonic transducer, near its distal end to assist in dissolution of occlusive materials, enhance drug uptake, or the like. Still further optionally, the inner catheter may comprise two or more lumens, where at least two of the lumens are joined near a distal end to permit mixing of two or more gas or liquid streams which are being delivered through the catheter. The mixed streams are then released through a common outlet port on the inner catheter. Alternatively, the two streams may be delivered in parallel from the distal tip of the inner catheter for a variety of purposes.
- The systems of the present invention may comprise further elements, such as guidewires, tracheal tubes with integral visualization (including both endotracheal and tracheostomy tubes), therapeutic or diagnostic reagents, and/or other system components intended to cooperate in performing the methods of the present invention as described in more detail below. Additionally, the systems of the present invention may be incorporated into kits where one or more system components are packaged together with instructions for use setting forth the methods described in more detail below. Such kits will usually further comprise packages for holding the system component(s) together with the instructions for use.
- Methods according to the present invention comprise using an isolation catheter and an inner catheter (generally as described above) for isolating a lobar or sub-lobar region of the lung and then performing a procedure within the isolated region. In a first instance, the methods are used for delivering a substance, typically a drug or other pharmaceutically active substance, to the isolated region. In a second instance, the methods are used for ravaging the isolated region, i.e., introducing and removing a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like, to the region. Optionally, the lavage and substance delivery methods can be combined where a drug or other active agent is included in the washing liquid which is being used for lavage. The methods of the present invention comprise positioning a distal end of the isolation catheter within a bronchial passage beyond a first branching within the right or left lung. The inner catheter is then positioned through the main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchial passage distally beyond the distal end of the isolation catheter. At least one occlusion element near the distal end of the isolation catheter is expanded within the bronchial passage to isolate a target lobar or sub-lobar region. Thereafter, in the case of drug or other substance delivery, the substance may be delivered through the inner catheter to the isolated region of the lung. In the case of lavage, the washing liquid may be infused through either (or both) of the inner catheter or the isolation catheter and aspirated through the other (or both) of the two catheters. Infusion and aspiration may be performed sequentially or concurrently, or in combinations of both sequential and concurrent infusion and aspiration. Often, it will be preferred to infuse the washing liquid through the inner catheter so that it enters the isolated region generally in a distal portion thereof and diffuses or migrates back toward the isolation catheter where it is collected and removed. In some instances, the washing liquid drug, or other substance may be introduced as a bolus and held or retained within the isolated sub-lobar region for a pre-selected retention time prior to initiating aspiration. In other instances, it may be desirable to continuously both infuse and aspirate the washing liquid drug, or other substance to get a “circulation” of the substance through the isolated lobar or sub-lobar region. Optionally, the washing liquid may comprise a drug or other biologically active substance to perform a therapeutic action while the region is being ravaged.
- In the case of substance delivery, the substance may comprise any one of a wide variety of pharmaceutical agents, including small molecule drugs, protein drugs, carbohydrate drugs, nucleic acid drugs (genes, optionally in combination with delivery vectors and/or expression control segments), and the like. The delivered substances may be in the form of an aerosol, optionally produced within the inner catheter or prior to introduction to the inner catheter. Still further optionally, the substance may comprise a liquid which is instilled through the inner catheter. For both substance delivery and lavage, it will frequently be preferred to position the isolation catheter and inner catheter through a visualizing endotracheal or tracheostomy tube which has been previously placed in the patient's trachea. Suitable visualizing endotracheal tubes are described, for example, in U.S. Pat. No. 5,285,778, the full disclosure of which is incorporated herein by reference. Usually, a visualizing endotracheal or tracheostomy tube will include an inflatable cuff or other occlusion element so that the whole lungs may be isolated from the upper regions of the trachea. In this way, the patient may be ventilated through the tracheal tube while other regions of the lung are isolated. Moreover, direct visualization at the bifurcation between the left and right lungs helps position in place the isolation catheter to the target region to be isolated. Additionally, the regions of the lung above or proximal to the occlusion element on the isolation catheter may be ventilated and maintained at a different pressure through the tracheal tube. Thus, by employing isolation cuffs on the tracheal tube, the isolation catheter, and the inner catheter, at least three isolated zones within the lung may be maintained with different pressures being simultaneously maintained. Moreover, different substances can be delivered to each of these regions through the lumens of the inner catheter, isolation catheter, and the tracheal tube, respectively. Often, pressure within the isolated region may be maintained higher than that within the proximal regions of the lung (where pressure is being controlled through the tracheal tube) resulting in expansion of the isolated region which may be beneficial for a variety of reasons. Alternatively, pressure within the isolated region may be maintained below that of the proximal portions of the lung, reducing the risk of release of materials from the isolated region into the proximal portions of the lung. Moreover, when the inner catheter has an isolation cuff, a third distal region of the lung may be pressurized separately from the intermediate and proximal regions.
- Introduction of the isolation catheter and/or inner catheter will preferably be performed over a guidewire. The guidewire will first be introduced to a point beyond the location in a bronchial passage where it is desired to position a distal end of the isolation catheter and/or inner catheter. Preferably the isolation catheter will comprise optical and illumination fibers which permit direct visual observation of the guidewire as the guidewire and isolation catheter are advanced. In particular, the guidewire and isolation catheter can be advanced in tandem so that, as successive bifurcations are approached, the physician can steer a curved end of the guidewire into the desired branch bronchial passage. After positioning the isolation catheter at its desired final location, an occlusion cuff may be expanded and the inner catheter optionally introduced over the guidewire or introduced directly through the main lumen of the isolation catheter without a guidewire. While the inner catheter may in some instances incorporate optical and illumination fibers, it will usually not have such imaging capabilities. Thus, positioning of the inner catheter will frequently be done solely by observation from the isolation catheter and/or under fluoroscopic or other external imaging. Of course, positioning of an isolation catheter can also be performed solely under fluoroscopic imaging (or in combination with both direct visual and fluoroscopic imaging), particularly when the isolation catheter does not include imaging capability.
- In a further specific aspect of the methods of the present invention, the inner catheter may be moved and repositioned within the bronchial passages of the isolated region to deliver a substance or release a washing fluid for lavage at different points within the region. Optionally, the inner catheter can be moved (i.e., advanced distally or drawn proximally) while the substance or washing liquid is being released in order to better distribute the material within the isolated region. Further optionally, the inner catheter could also be moved through the isolated region in order to aspirate materials which have been introduced, either alone or in combination with aspiration through the main lumen of the isolation catheter.
- Kits according to the present invention include at least an isolation catheter, and optionally include an inner catheter, a tracheal tube, and/or a guidewire. Other components including medical and bioactive reagents, e.g., drugs, washing liquids, or the like, may also be provided within the kits. In addition to the isolation catheter and optional other system components, the kits will comprise instructions for use setting forth a method of the present invention as generally set forth above. The kits will usually be packaged together in conventional medical packaging, such as a pouch, tray, tube, box, bag, or the like. Instructions for use may be provided on a separate printed sheet, or may printed in whole or in part on the packaging materials. When printed separately, the instructions are commonly referred to as a package insert. Usually, at least the isolation catheter and other components of the kit which would be used in the procedure will be packaged in a sterile manner within the kit.
- FIG. 1 is a side view of a sub-lobar isolation catheter constructed in accordance with the principles of the present invention.
- FIG. 1A is a cross-sectional view taken along
line 1A-1A in FIG. 1. - FIG. 1B is an alternative cross-sectional view similar to that shown in FIG. 1A.
- FIG. 2 is a side view of a first alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
- FIG. 2A is a cross-sectional view taken along
line 2A-2A of FIG. 2. - FIG. 3 is a side view of a second alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
- FIG. 3A is a cross-sectional view taken along
line 3A-3A of FIG. 3. - FIG. 4 illustrates a system comprising a sub-lobar isolation catheter and an inner catheter constructed in accordance with the principles of the present invention.
- FIG. 5 is a side view of the inner catheter of FIG. 4 mounted within the sub-lobar isolation catheter, with portions broken away.
- FIG. 6 illustrates a first alternative construction of the inner catheter of the present invention.
- FIG. 6A is a cross-sectional view taken along
line 6A-6A of FIG. 6. - FIG. 7 is a second alternative construction of the inner catheter of the present invention.
- FIG. 7A is a cross-sectional view taken along
line 7A-7A of FIG. 7. - FIG. 8 is a third alternative construction of the inner catheter of the present invention.
- FIG. 8A is a cross-sectional view taken along
line 8A-8A of FIG. 8. - FIG. 8B is a detailed view of the distal end of the catheter of FIG. 8 taken along
line 8B-8B of FIG. 8. - FIG. 9 is a fourth alternative construction of the inner catheter of the present invention.
- FIG. 9A is a cross-sectional view taken along
line 9A-9A of FIG. 9. - FIG. 10 illustrates introduction of a sub-lobar isolation catheter to a diseased region within a lung according to the method of the present invention.
- FIG. 11 is a detailed view of the introduction of FIG. 10 shown with the isolation catheter being passed through a visualizing endotracheal tube.
- FIGS.12A-12C illustrate use of the various inner catheters for performing particular procedures in accordance with the principles of the present invention.
- FIG. 13 illustrates a kit constructed in accordance with the principles of the present invention.
- Isolation of a lobar or sub-lobar region of the lung is accomplished by occluding a lumen of a bronchial passage (bronchiole) at a location distal to a first branch in the network of bronchial passages within the right or left lung. Substances may be delivered to and/or a washing fluid may be used to lavage the isolated lobar or sub-lobar region of the lung by introducing or exchanging materials through a lumen of an isolation catheter, usually in combination with delivery or exchange through a lumen of an associated inner catheter. An inflatable cuff or other expansible isolation element on the isolation catheter is positioned at an isolation location within the bronchial passage, and the cuff inflated. The inner catheter is then positioned at a desired location distal to the end of the isolation catheter, and the isolated region is thus accessible through at least two access lumens, i.e., one lumen through the inner catheter and a second annular lumen between the exterior of the inner catheter and the interior luminal wall of the isolation catheter. These access lumens may be used separately or in combination in a variety of ways to perform the methods of the present invention. The apparatus and methods of the present invention will now be described in greater detail.
- Referring to FIGS. 1 and 1A, an
isolation catheter 10 comprises acatheter body 12 having aproximal end 16 and adistal end 14. Aninflatable isolation cuff 18 is disposed near thedistal end 14 of thecatheter body 12, and aninflation lumen 20 extends through the catheter body from aproximal port 22 onproximal hub 24 to theballoon 18. Thecatheter 10 further comprises an optical fiber or bundle 24 and an illumination fiber orbundle 26, both of which are brought out to asuitable connector 28 through a connectingcable 30. Theoptical fiber 24 and illuminatingfiber 26 may be plugged into a variety of conventional imaging consoles which can provide a real time, visual image looking forwardly from thedistal end 14 of thecatheter body 12. Suitable commercial imaging consoles are available from suppliers, such as Pulmonx, Palo Alto, Calif., assignee of the present application as well as Olympus, Pentax and Stryker. Thecatheter body 12 further includes amain lumen 32 which extends the entire length of the catheter body and passes through connector hub 36 toproximal connector 34. As will be discussed in more detail below, themain lumen 32 can be used for introducing and/or aspirating materials which are introduced to or withdrawn from an isolated lobar or sub-lobar region of the lung. Most usually, themain lumen 32 will receive an inner catheter (FIGS. 4 and 5 below), and the isolation catheter and inner catheter will be utilized together for delivering, collecting, and removing materials from an isolated sub-lobar region of the lung. - As shown in FIGS. 1 and 1A, the
catheter body 12 of theisolation catheter 10 is a single extrusion having four lumens or passages formed therein. Two of the lumens form theinflation lumen 20 and themain lumen 32, while the other two lumens house theoptical fiber bundle 24 and theillumination fiber bundle 26. Thecatheter body 12 could also be formed from a plurality of separate tubular members which are held together by an outer cover, as illustrated in FIG. 11B. For example, aninner tube 40 can be disposed in parallel with theoptical fiber bundle 24 and the illuminatingfiber bundle 26. Aseparate tubular member 42 can also be placed co-axially on the exterior oftube 40, and all of the components held together by a cover 44 which may, for example, be shrink-wrapped over the assembly. Aninflation lumen 46 is then provided in the space under the cover 44 which is unoccupied by the optical and tubular components. A variety of other specific construction designs may also be provided. - The
catheter body 12 may be formed from conventional materials, such as polyamides (nylons), polyethylenes, polyurethanes, polytetrafluoroethylenes (PTFEs), polyimides, and the like. The inflatable cuff can be formed from other conventional materials, such as polyvinylchloride, polyurethanes, high density polyethylenes, low density polyethylenes, nylons, PTFEs, and the like. Exemplary and preferred dimensions for thecatheter body 12 of theisolation catheter 10 have been set forth above. - A second
exemplary isolation catheter 50 constructed in accordance with the principles of the present invention is illustrated in FIGS. 2 and 2A. The construction ofisolation catheter 50 is generally the same as that forisolation catheter 10, and like components will be given like numbers. The principal difference between thecatheters catheter 50 includes alens washing lumen 52 which extends fromlens washing port 54 in thehub 56 to a position at the distal tip of the catheter body which lies immediately over a lens (not shown) formed at the distal end of the optical fiber orbundle 26. Because of the humid and contaminating nature of the lungs, it will be a significant benefit to be able to wash the optical viewing lens whenever the lens becomes obscured to do condensation or fouling. - A third exemplary construction of the isolation catheter of the present invention is illustrated in FIGS. 3 and 3A. There, an
isolation catheter 60 comprises generally the same components ascatheters catheter body 12 further includes alumen 62 which receives a guidewire (or alternatively an articulating steering mechanism) and which extends fromport 64 onhub 66 to thedistal end 14 of thecatheter body 12. Thus,isolation catheter 60 is specially adapted for introduction over a guidewire (or other steering mechanism) according to the methods of the present invention and as described in more detail below. It will be appreciated, of course, that the earlier embodiments could also be introduced over a guidewire where the guidewire is passed through themain lumen 32, but in such cases the main lumen would have to be emptied i.e., the inner catheter (if used) would have to be removed from the isolation catheter. Optionally, theisolation catheter 60 can also include avibratory element 66 near its distal end. The vibratory element could be a mechanically driven surface, but will usually comprise an ultrasonic transducer intended to deliver vibratory energy to disrupt blockages in the bronchus, enhance drug delivery, or the like. -
Systems 70 according to the present invention comprise an isolation catheter 10 (or any of the other isolation catheters described above or which would come within the principles of the present invention) and aninner catheter 80. As illustrated in FIGS. 4 and 5, theinner catheter 80 is sized and adapted to fit within themain lumen 32 of theisolation catheter 10. Theinner catheter 80 has adistal end 82 and aproximal end 84 which terminates in a connectinghub 86. Theisolation catheter 10 includes a hub 96 which is similar to the previously described hubs, except that a proximal end has been modified to slidably receive theinner catheter 80. As shown, an O-ring 90 is provided to provide a sliding pneumatic or hydraulic seal about the inner catheter. Additionally, anaccess port 92 is provided in the hub 96 to permit communication with theannular lumen 94 disposed between the exterior ofinner catheter 80 and the interior of themain lumen 32 of theisolation catheter 10. In this way, materials can be withdrawn or introduced through theisolation catheter 10 as well as through the lumen of theinner catheter 80. More particularly, it permits two spaced-apart access points, i.e., at the distal ends of theisolation catheter 10 andinner catheter 80, respectively, to be established within an isolated lobar or sub-lobar region of the lungs. Using two access points, a variety of substance delivery and lavage protocols can be run, as described in more detail below. - A first alternative embodiment of an
inner catheter 100 is illustrated in FIGS. 6 and 6A.Inner catheter 100 includescatheter body 102 having aninflatable isolation cuff 104 near its distal end. A plurality of infusion/aspiration ports 106 are also formed near thedistal end 103 of thecatheter body 102 and are connected by alumen 108 to an aspiration/infusion port 110 inproximal hub 112. Theinflatable cuff 104 may be inflated by connecting a suitable inflation source toconnector 114 which delivers the inflation medium throughlumen 116 to thecuff 104. Acentral lumen 120 extends the length of the catheter body from itsdistal end 103 to aconnection port 122 in thehub 112. By providing the infusion/aspiration ports 106 proximal to theinflatable cuff 104, it will be appreciated that substances may be delivered or removed from a region which is proximal to thecuff 104 but distal to the isolation cuff on the isolation catheter with which theinner catheter 100 is used. - Yet a further alternative embodiment of an
inner catheter 130 is illustrated in FIGS. 7 and 7A. Theinner catheter 130 includes an ultrasonic or other vibratory element 132 (shown in broken line) at or near itsdistal end 134. Theultrasonic element 132 may be positioned at the distal end of alumen 136 which extends through the length of thecatheter 130. Thelumen 136 may thus hold wires necessary to power the ultrasonic transducer, where the wires are brought out through a connectingcable 140 and terminate in aplug 142. An aspiration/infusion lumen 150 also extends the length of thecatheter 130 and terminates in a luer or other connector 152 at the proximal end of the catheter. Optionally, a similar ultrasonic or other vibratory element may be disposed on the isolation catheter, either in addition to or in place of thevibration element 132 on the inner catheter. Although shown proximal tocuff 18, thevibratory element 66 may also be placed distal to the cuff to deliver energy into an isolated region. - Referring now to FIGS. 8, 8A, and8B, still a further embodiment of an
inner catheter 160 will be described. Thecatheter 160 comprises acatheter body 162 having adistal end 164 and aproximal end 166. A pair oflumens catheter body 162 fromports 172 and 174, respectively, and proximal hub of 176 to each of thelumens ports 172 and 174 to amixing region 180 near adistal instillation port 182 at a distal tip of the catheter. For example, air or other gas may be delivered through thelarger lumen 170 so that it flows the mixingarea 180. By delivering a liquid or powder through thesmaller lumen 168, the airflow can act as a Venturi in suspending an aerosolizing material which is delivered to the mixing area. In this way, droplets or particulates can be delivered or instilled directly within an isolated lobar or sub-lobar region of the lung. By properly controlling the particulate or droplet size, i.e., to arrange generally between 0.1 μm to 5 μm, absorption of these materials into the alveolar regions of the lungs can be enhanced. By controlling the particulate or droplet size outside this range, usually above 5 μm, preferably above 10 μm, local delivery (i.e., not systemically absorbed) of a drug or other substance can be achieved. - Referring now to FIGS. 9 and 9A, still yet a further embodiment of an
inner catheter 200 constructed in accordance with the principles of the present invention will be described. Theinner catheter 200 comprises acatheter body 202 having adistal end 204 and aproximal end 206. The catheter body includes acentral lumen 210 and a pair ofinstillation lumens lumens 212 and air or other aerosolization gas through theother lumen 214. Thecentral lumen 210 could be used for aspiration, delivery of other drug materials, or the like. - Referring now to FIGS. 10, 11, and12A-12C, methods according to the present invention will be described. Most generally, an
isolation catheter 10 may be introduced through the mouth, the trachea T and into a lobe L of the lung until it reaches a diseased region DR. Alternatively, theisolation catheter 10 could be introduced through an incision in the neck, usually through a tracheostomy tube. At that point,cuff 18 may be inflated to isolate regions of the lung distal to the inflated cuff in the bronchial passage. As illustrated in FIG. 11,catheter 10 may optionally be delivered through a visualizing endotracheal tube VETT (or visualizing tracheostomy tube), where a cuff C on the tube is inflated within the trachea T at a region just above the main lung bifurcation into the right and left lungs RL and LL. Further optionally, theisolation catheter 10 may be advanced over a guidewire GW, where visualization of the guidewire immediately ahead of the catheter may be observed on the video screen V attached to the optical and illumination fibers within thecatheter 10. In particular, the guidewire may be advanced just ahead of the distal end of thecatheter 10 in tandem so that the guidewire can be observed as it is rotated and introduced selectively into the bronchial passages at bifurcations. Alternatively, or additionally, advancement of thecatheter 10 may be observed fluoroscopically or using any other available external imaging systems. - Once the
catheter 10 is in place beyond a second bifurcation SB in the bronchial passages, as illustrated in FIG. 12A, theinflatable cuff 18 may be inflated to both anchor the distal end of the catheter and isolate regions of the lung distal thereto. After thecuff 18 is inflated, theinner catheter 80 may be advanced through themain lumen 34 so that thedistal end 82 of the inner catheter progresses distally into a desired bronchial passage. Advancement of thedistal end 82 may optionally be over a guidewire and will usually be performed under visual imaging using the optical illuminating fibers in theisolation catheter 10. Once the inner catheter has been properly positioned, as shown in FIG. 12B, a desired procedure can be performed. For example, a drug can be delivered through thedistal end 82 of the inner catheter to treat a target region TR, shown in broken line in FIG. 12B, additionally or alternatively, the target region TR can be lavaged by introducing a washing fluid through eithercatheter catheter - Alternatively, as shown in FIG. 12C,
inner catheter 100 havinginflatable cuff 104 at its distal end may be introduced through theisolation catheter 10. By then inflatingcuff 104 distally relative to cuff 18 onisolation catheter 10, a modified target region MTR can be defined. In particular, the target region MTR in FIG. 12C will be more limited in volume than that formed in FIG. 12B where there is no distal isolation. Use of thesecond isolation cuff 104 on theinner catheter 100 permits much more specifically focused treatment protocols, both drug delivery and lavage, to be performed. By delivering or aspirating the materials through theports 106, it will be appreciated that the treatment is substantially limited to between the twocuffs - Referring now to FIG. 13, a
kit 300 according to the present invention will comprise at least a lobar orsub-lobar isolation catheter 10 and aninner catheter 80 together with instructions for use IFU. Optionally, the kits may further include other system components as described above, such as a visualizing endotracheal tube VET, a guidewire GW, and/or various reagents (not shown). The instructions for use IFU will set forth any of the methods as described above, and all kit components will usually be packaged together in asuitable package 350, such as a pouch, tray, tube, box, bag, or the like. Usually, those kits components, such as theisolation catheter 10 andinner catheter 80, which will be used in performing the procedure on the patient, will be sterilized and maintained sterilely within the kit. Optionally, separate pouches, bags, trays, or other packaging materials may be provided within a larger package, where the smaller packs may be separately opened and will separately maintain the components in a sterile fashion. - While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
Claims (17)
1. An isolation catheter comprising:
a catheter body having a proximal end, a distal end, and a main lumen therethrough;
an expansible occlusion member disposed on the catheter body near the distal end thereof;
optical and illumination fibers disposed in the catheter body to image a region distal to the distal end of the catheter body; and
a hub attached to the proximal end of the catheter body, said hub having a connector port for at least the main lumen.
2. An isolation catheter as in claim 1 , wherein the catheter body has a length in the range from 20 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm and the main lumen has a diameter from 1 mm to 6 mm.
3. An isolation catheter as in either claim 1 or 2, wherein the expansible occlusion member is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm and a length in the range from 5 mm to 30 mm.
4. An isolation catheter as in claim 3 , wherein the catheter body further comprises an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff and wherein the hub has an additional connector port for the inflation lumen.
5. An isolation catheter as in either claim 1 or 2, wherein the catheter body further comprises a lumen disposed to direct a washing fluid over a distal tip of the optical fiber.
6. An isolation lung infusion/aspiration system, said system comprising:
an isolation catheter according to either of claims 1 and 2; and
an inner catheter having a proximal end, a distal end, and a central lumen therethrough, said inner catheter being positionable within the main lumen of the sub-lobar isolation catheter to form an annular lumen within the main lumen.
7. A system as in claim 6 , wherein the hub has an additional connector port for the annular lumen.
8. A system as in claim 6 , further comprising an adaptor connectable to the hub, wherein the adaptor has a connector port for the annular lumen.
9. A system as in claim 6 , wherein the inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, an inner diameter in the range from 0.1 mm to 3.5 mm, and a length at least 10 cm longer than the isolation catheter.
10. A system as in claim 9 , wherein the inner catheter has a length in the range from 50 cm to 200 cm.
11. A system as in claim 6 , wherein the inner catheter has an expansible occlusion member disposed near its distal end.
12. A system as in claim 11 , wherein the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, and a length in the range from 5 mm to 30 mm.
13. A system as in claim 11 , wherein the inner catheter further comprises an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff on the inner catheter.
14. A system as in claim 6 , wherein the inner catheter further comprises an infusion/aspiration lumen having at least one distal port positioned proximally of the inflatable cuff on the inner catheter.
15. A system as in claim 6 , wherein the inner catheter further comprises a vibratory element near the distal end thereof.
16. A system as in claim 6 , wherein the inner catheter comprises at least two lumens which are joined near a distal end of the inner catheter and which have a common outlet port.
17. An isolation catheter as in claim 1 or 2, further comprising a vibratory element near the distal end thereof.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/425,272 US6398775B1 (en) | 1999-10-21 | 1999-10-21 | Apparatus and method for isolated lung access |
PCT/US2000/029417 WO2003105941A1 (en) | 1999-10-21 | 2000-10-24 | Apparatus and method for isolated lung access |
US10/074,861 US20020077593A1 (en) | 1999-10-21 | 2002-02-11 | Apparatus and method for isolated lung access |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/425,272 US6398775B1 (en) | 1999-10-21 | 1999-10-21 | Apparatus and method for isolated lung access |
PCT/US2000/029417 WO2003105941A1 (en) | 1999-10-21 | 2000-10-24 | Apparatus and method for isolated lung access |
US10/074,861 US20020077593A1 (en) | 1999-10-21 | 2002-02-11 | Apparatus and method for isolated lung access |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/425,272 Division US6398775B1 (en) | 1999-10-21 | 1999-10-21 | Apparatus and method for isolated lung access |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020077593A1 true US20020077593A1 (en) | 2002-06-20 |
Family
ID=32234041
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/425,272 Expired - Lifetime US6398775B1 (en) | 1999-10-21 | 1999-10-21 | Apparatus and method for isolated lung access |
US10/074,861 Abandoned US20020077593A1 (en) | 1999-10-21 | 2002-02-11 | Apparatus and method for isolated lung access |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/425,272 Expired - Lifetime US6398775B1 (en) | 1999-10-21 | 1999-10-21 | Apparatus and method for isolated lung access |
Country Status (2)
Country | Link |
---|---|
US (2) | US6398775B1 (en) |
WO (1) | WO2003105941A1 (en) |
Cited By (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020095209A1 (en) * | 1997-09-16 | 2002-07-18 | Gholam-Reza Zadno-Azizi | Body fluid flow control device |
US20020112729A1 (en) * | 2001-02-21 | 2002-08-22 | Spiration, Inc. | Intra-bronchial obstructing device that controls biological interaction with the patient |
US20030070682A1 (en) * | 2001-10-11 | 2003-04-17 | Wilson Peter M. | Bronchial flow control devices and methods of use |
US20030158515A1 (en) * | 2002-02-21 | 2003-08-21 | Spiration, Inc. | Device and method for intra-bronchial provision of a therapeutic agent |
US20030183235A1 (en) * | 2001-10-25 | 2003-10-02 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
US20030195385A1 (en) * | 2002-04-16 | 2003-10-16 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US20030212412A1 (en) * | 2002-05-09 | 2003-11-13 | Spiration, Inc. | Intra-bronchial obstructing device that permits mucus transport |
US20030216769A1 (en) * | 2002-05-17 | 2003-11-20 | Dillard David H. | Removable anchored lung volume reduction devices and methods |
US20030228344A1 (en) * | 2002-03-08 | 2003-12-11 | Fields Antony J. | Methods and devices for inducing collapse in lung regions fed by collateral pathways |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
EP1386635A1 (en) * | 2002-07-31 | 2004-02-04 | Cordis Corporation | Long term oxygen therapy system |
US20040039250A1 (en) * | 2002-05-28 | 2004-02-26 | David Tholfsen | Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment |
US20040055606A1 (en) * | 2001-03-02 | 2004-03-25 | Emphasys Medical, Inc. | Bronchial flow control devices with membrane seal |
US20040060563A1 (en) * | 2001-03-02 | 2004-04-01 | Alan Rapacki | Bronchial flow control devices and methods of use |
US6722360B2 (en) | 2000-06-16 | 2004-04-20 | Rajiv Doshi | Methods and devices for improving breathing in patients with pulmonary disease |
US20040074491A1 (en) * | 2001-03-02 | 2004-04-22 | Michael Hendricksen | Delivery methods and devices for implantable bronchial isolation devices |
US20040078054A1 (en) * | 1998-06-05 | 2004-04-22 | Broncus Technologies, Inc. | Method for lung volume reduction |
US20040148035A1 (en) * | 2002-11-27 | 2004-07-29 | Michael Barrett | Delivery methods and devices for implantable bronchial isolation devices |
US20040200484A1 (en) * | 2003-04-08 | 2004-10-14 | Springmeyer Steven C. | Bronchoscopic lung volume reduction method |
US20040210248A1 (en) * | 2003-03-12 | 2004-10-21 | Spiration, Inc. | Apparatus, method and assembly for delivery of intra-bronchial devices |
WO2004064885A3 (en) * | 2003-01-20 | 2004-10-21 | Pulmonx | Methods and arrangement for reducing the volume of the lung |
US20040206349A1 (en) * | 2001-09-11 | 2004-10-21 | Alferness Clifton A. | Removable lung reduction devices, systems, and methods |
US20040243393A1 (en) * | 2003-05-29 | 2004-12-02 | Microsoft Corporation | Semantic object synchronous understanding implemented with speech application language tags |
US20050051163A1 (en) * | 2000-03-04 | 2005-03-10 | Deem Mark E. | Methods and devices for use in performing pulmonary procedures |
US20050137714A1 (en) * | 2003-08-08 | 2005-06-23 | Gonzalez Hugo X. | Bronchoscopic repair of air leaks in a lung |
US20050178389A1 (en) * | 2004-01-27 | 2005-08-18 | Shaw David P. | Disease indications for selective endobronchial lung region isolation |
US20050196344A1 (en) * | 2004-02-27 | 2005-09-08 | Mccutcheon John | Methods and devices for blocking flow through collateral pathways in the lung |
US20050203400A1 (en) * | 2003-05-10 | 2005-09-15 | Zappala Stephen M. | System and method for precisely identifying a configuration of an anatomical space in real time |
US20050222500A1 (en) * | 2004-03-01 | 2005-10-06 | Fujinon Corporation | Endoscope system and operation method for endoscope |
US20060004305A1 (en) * | 2002-11-27 | 2006-01-05 | George Robert M | Delivery methods and devices for implantable bronchial isolation devices |
US20060009748A1 (en) * | 2004-06-16 | 2006-01-12 | Mathis Mark L | Method of compressing a portion of a lung |
US20060020347A1 (en) * | 2004-03-08 | 2006-01-26 | Michael Barrett | Implanted bronchial isolation devices and methods |
US20060030863A1 (en) * | 2004-07-21 | 2006-02-09 | Fields Antony J | Implanted bronchial isolation device delivery devices and methods |
US20060032505A1 (en) * | 2004-08-13 | 2006-02-16 | Engineered Medical Systems, Inc. | Perilaryngeal oral airway with multi-lumen esophogeal-obturator |
EP1669095A1 (en) | 2004-12-10 | 2006-06-14 | Nitinol Development Corporation | Collateral ventilation device with chest tube/evacuation features |
US20060144398A1 (en) * | 2004-12-08 | 2006-07-06 | Rajiv Doshi | Respiratory devices |
US20060206147A1 (en) * | 2002-02-21 | 2006-09-14 | Devore Lauri J | Intra-bronchial obstruction device that provides a medicant intra-bronchially to the patient |
US20060235432A1 (en) * | 2002-02-21 | 2006-10-19 | Devore Lauri J | Intra-bronchial obstructing device that controls biological interaction with the patient |
US20060258903A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Method of inserting a feeding tube |
US20060258904A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Feeding tube and track |
US20060258902A1 (en) * | 2005-05-13 | 2006-11-16 | Spivey James T | Apparatus useful for positioning a device on an endoscope |
US20060258910A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Method of positioning a device on an endoscope |
US20060258907A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Track for medical devices |
US20070005083A1 (en) * | 1997-04-30 | 2007-01-04 | Sabaratham Sabanathan | Occlusion device |
EP1757322A1 (en) * | 2005-08-23 | 2007-02-28 | Nitinol Development Corporation | Collateral ventilation bypass system with retention features |
US20070063687A1 (en) * | 2005-09-20 | 2007-03-22 | Dacheng Zhou | Circuit and method for bias voltage generation |
US20070232992A1 (en) * | 2006-03-31 | 2007-10-04 | James Kutsko | Articulable anchor |
US20070235846A1 (en) * | 2006-04-01 | 2007-10-11 | Stats Chippac Ltd. | Integrated circuit package system with net spacer |
US20070293727A1 (en) * | 2004-04-21 | 2007-12-20 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
EP1888156A2 (en) * | 2005-05-13 | 2008-02-20 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US20080041373A1 (en) * | 2006-06-07 | 2008-02-21 | Ventus Medical, Inc. | Nasal devices |
US20080119693A1 (en) * | 2004-04-21 | 2008-05-22 | Acclarent, Inc. | Methods and Apparatus for Treating Disorders of the Ear, Nose and Throat |
US20080125626A1 (en) * | 2004-04-21 | 2008-05-29 | Acclarent, Inc. | Devices, Systems and Methods Useable for Treating Sinusitis |
US20080132938A1 (en) * | 2004-04-21 | 2008-06-05 | Acclarent, Inc. | Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat |
US20080178874A1 (en) * | 2006-11-16 | 2008-07-31 | Ventus Medical, Inc. | Adjustable nasal devices |
US20080287908A1 (en) * | 2004-04-21 | 2008-11-20 | Acclarent, Inc. | Ethmoidotomy System and Implantable Spacer Devices Having Therapeutic Substance Delivery Capability for Treatment of Paranasal Sinusitis |
US20080287878A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Pulmonary visceral pleura anastomosis reinforcement |
US20090050144A1 (en) * | 2004-12-08 | 2009-02-26 | Ryan Kendall Pierce | Adhesive nasal respiratory devices |
US20090205651A1 (en) * | 2008-02-19 | 2009-08-20 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US7615005B2 (en) | 2003-05-16 | 2009-11-10 | Ethicon Endo-Surgery, Inc. | Medical apparatus for use with an endoscope |
US20090306544A1 (en) * | 2008-06-09 | 2009-12-10 | Ho-Kin Ng | Instillation/aspiration device |
US20090301480A1 (en) * | 2008-06-09 | 2009-12-10 | Mamdouh Elsakka | Diagnostic sample collection system and method of use |
US20090306545A1 (en) * | 2008-06-09 | 2009-12-10 | Mamdouh Elsakka | Bronchoalveolar lavage catheter assembly |
US20090318757A1 (en) * | 2008-06-23 | 2009-12-24 | Percuvision, Llc | Flexible visually directed medical intubation instrument and method |
US7670282B2 (en) | 2004-06-14 | 2010-03-02 | Pneumrx, Inc. | Lung access device |
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US7686013B2 (en) | 2006-01-17 | 2010-03-30 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7753052B2 (en) | 2003-06-05 | 2010-07-13 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system |
US7766938B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US7771472B2 (en) | 2004-11-19 | 2010-08-10 | Pulmonx Corporation | Bronchial flow control devices and methods of use |
US7789083B2 (en) | 2003-05-20 | 2010-09-07 | Portaero, Inc. | Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease |
US7806120B2 (en) | 2004-12-08 | 2010-10-05 | Ventus Medical, Inc. | Nasal respiratory devices for positive end-expiratory pressure |
US7811274B2 (en) | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7856979B2 (en) | 2006-05-23 | 2010-12-28 | Ventus Medical, Inc. | Nasal respiratory devices |
US20110017207A1 (en) * | 2001-03-02 | 2011-01-27 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US7896008B2 (en) | 2003-06-03 | 2011-03-01 | Portaero, Inc. | Lung reduction system |
US20110060214A1 (en) * | 2004-04-21 | 2011-03-10 | Acclarent, Inc. | Systems and Methods for Performing Image Guided Procedures Within the Ear, Nose, Throat and Paranasal Sinuses |
US7905830B2 (en) | 2005-05-13 | 2011-03-15 | Ethicon Endo-Surgery, Inc. | Sheath for use with an endoscope |
US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US20110112512A1 (en) * | 2004-04-21 | 2011-05-12 | Acclarent, Inc. | Devices and methods for treating maxillary sinus disease |
US8021385B2 (en) | 2002-03-20 | 2011-09-20 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US8020700B2 (en) | 2007-12-05 | 2011-09-20 | Ventus Medical, Inc. | Packaging and dispensing nasal devices |
US20110226238A1 (en) * | 2000-03-04 | 2011-09-22 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
US20110251457A1 (en) * | 2010-04-08 | 2011-10-13 | Eric James Kezirian | Endoscopic device and system |
US8043301B2 (en) | 2007-10-12 | 2011-10-25 | Spiration, Inc. | Valve loader method, system, and apparatus |
US8062315B2 (en) * | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8136230B2 (en) | 2007-10-12 | 2012-03-20 | Spiration, Inc. | Valve loader method, system, and apparatus |
US8142455B2 (en) | 2006-03-13 | 2012-03-27 | Pneumrx, Inc. | Delivery of minimally invasive lung volume reduction devices |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US8632605B2 (en) | 2008-09-12 | 2014-01-21 | Pneumrx, Inc. | Elongated lung volume reduction devices, methods, and systems |
US20140081252A1 (en) * | 2012-09-14 | 2014-03-20 | The Spectranetics Corporation | Tissue slitting methods and systems |
US8702626B1 (en) | 2004-04-21 | 2014-04-22 | Acclarent, Inc. | Guidewires for performing image guided procedures |
US8721591B2 (en) | 2004-04-21 | 2014-05-13 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US8721734B2 (en) | 2009-05-18 | 2014-05-13 | Pneumrx, Inc. | Cross-sectional modification during deployment of an elongate lung volume reduction device |
US8740921B2 (en) | 2006-03-13 | 2014-06-03 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8747389B2 (en) | 2004-04-21 | 2014-06-10 | Acclarent, Inc. | Systems for treating disorders of the ear, nose and throat |
US8764729B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Frontal sinus spacer |
US8795241B2 (en) | 2011-05-13 | 2014-08-05 | Spiration, Inc. | Deployment catheter |
US20140275777A1 (en) * | 2013-03-15 | 2014-09-18 | Erhan H. Gunday | Resector Balloon Catheter With Multi-Port Hub |
US8870893B2 (en) | 2004-04-21 | 2014-10-28 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
US8875711B2 (en) | 2010-05-27 | 2014-11-04 | Theravent, Inc. | Layered nasal respiratory devices |
US8876791B2 (en) | 2005-02-25 | 2014-11-04 | Pulmonx Corporation | Collateral pathway treatment using agent entrained by aspiration flow current |
US8894614B2 (en) | 2004-04-21 | 2014-11-25 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
US8932276B1 (en) | 2004-04-21 | 2015-01-13 | Acclarent, Inc. | Shapeable guide catheters and related methods |
US8951225B2 (en) | 2005-06-10 | 2015-02-10 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
US9089258B2 (en) | 2004-04-21 | 2015-07-28 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9101384B2 (en) | 2004-04-21 | 2015-08-11 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat |
US9107574B2 (en) | 2004-04-21 | 2015-08-18 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9125639B2 (en) | 2004-11-23 | 2015-09-08 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US9155492B2 (en) | 2010-09-24 | 2015-10-13 | Acclarent, Inc. | Sinus illumination lightwire device |
US9211181B2 (en) | 2004-11-19 | 2015-12-15 | Pulmonx Corporation | Implant loading device and system |
US9308361B2 (en) | 2005-01-18 | 2016-04-12 | Acclarent, Inc. | Implantable devices and methods for treating sinusitis and other disorders |
CN105536081A (en) * | 2016-01-22 | 2016-05-04 | 长江大学 | Full-automatic body cavity effusion and pneumatosis extraction instrument |
US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
US9399121B2 (en) | 2004-04-21 | 2016-07-26 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US9468362B2 (en) | 2004-04-21 | 2016-10-18 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US20170135560A1 (en) * | 2015-11-18 | 2017-05-18 | Art Healthcare Ltd. | Sheath and hub for imaging endoscope |
US9737195B2 (en) | 2013-03-15 | 2017-08-22 | Sanovas, Inc. | Handheld resector balloon system |
US20170258983A1 (en) * | 2016-03-11 | 2017-09-14 | Hans Utz | Illuminated medical infusion |
US20170311792A1 (en) * | 2010-10-18 | 2017-11-02 | Erhan H. Gunday | Anchored Working Channel |
US9820688B2 (en) | 2006-09-15 | 2017-11-21 | Acclarent, Inc. | Sinus illumination lightwire device |
US9826999B2 (en) | 2004-04-21 | 2017-11-28 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US9833354B2 (en) | 2004-12-08 | 2017-12-05 | Theravent, Inc. | Nasal respiratory devices |
US10076441B2 (en) | 2009-06-19 | 2018-09-18 | Braincool Ab | Devices for cooling the nasal cavity |
US10188413B1 (en) | 2004-04-21 | 2019-01-29 | Acclarent, Inc. | Deflectable guide catheters and related methods |
CN109498966A (en) * | 2019-01-11 | 2019-03-22 | 上海市肺科医院 | Bronchogenic tuberculosis auxiliary therapeutic apparatus under a kind of airway wall |
US10362927B2 (en) * | 2013-02-01 | 2019-07-30 | Deka Products Limited Partnership | Endoscope with pannable camera |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
US10610228B2 (en) | 2004-12-08 | 2020-04-07 | Theravent, Inc. | Passive nasal peep devices |
US10624733B2 (en) | 2015-03-24 | 2020-04-21 | Spiration, Inc. | Airway stent |
US10639452B2 (en) | 2006-07-13 | 2020-05-05 | Best Medical International, Inc. | Echo-opaque urethral catheter |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
WO2021011408A1 (en) | 2019-07-12 | 2021-01-21 | Bard Access Systems, Inc. | Tubing with integrated optical fiber, medical devices, and methods thereof |
US11529502B2 (en) | 2004-04-21 | 2022-12-20 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US12004707B2 (en) | 2018-04-17 | 2024-06-11 | The Board Of Trustees Of The Leland Stanford Junior University | Airway visualization system |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7892229B2 (en) | 2003-01-18 | 2011-02-22 | Tsunami Medtech, Llc | Medical instruments and techniques for treating pulmonary disorders |
US8016823B2 (en) | 2003-01-18 | 2011-09-13 | Tsunami Medtech, Llc | Medical instrument and method of use |
US20060135947A1 (en) | 2000-10-27 | 2006-06-22 | Pulmonx | Occlusal stent and methods for its use |
US7549987B2 (en) | 2000-12-09 | 2009-06-23 | Tsunami Medtech, Llc | Thermotherapy device |
US9433457B2 (en) | 2000-12-09 | 2016-09-06 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US6609521B1 (en) * | 2001-04-09 | 2003-08-26 | Regents Of The University Of Minnesota | Endotracheal tube |
JP4409123B2 (en) * | 2001-07-19 | 2010-02-03 | オリンパス株式会社 | Medical obturator |
US7883471B2 (en) * | 2001-09-10 | 2011-02-08 | Pulmonx Corporation | Minimally invasive determination of collateral ventilation in lungs |
US8444636B2 (en) | 2001-12-07 | 2013-05-21 | Tsunami Medtech, Llc | Medical instrument and method of use |
DE10321990B4 (en) * | 2003-05-15 | 2005-10-13 | Microcuff Gmbh | Trachealbeatmungungsvorrichtung |
US20040236279A1 (en) * | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Gaseous therapeutic agent delivery |
US7533667B2 (en) | 2003-05-29 | 2009-05-19 | Portaero, Inc. | Methods and devices to assist pulmonary decompression |
US9301829B2 (en) † | 2003-07-30 | 2016-04-05 | Boston Scientific Scimed, Inc. | Embolic protection aspirator |
US8579892B2 (en) | 2003-10-07 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
EP2286863A3 (en) * | 2004-01-09 | 2011-03-23 | Corazon Technologies, Inc. | Multilumen catheters and methods for their use |
US20060047291A1 (en) * | 2004-08-20 | 2006-03-02 | Uptake Medical Corporation | Non-foreign occlusion of an airway and lung collapse |
US20060162731A1 (en) * | 2004-11-16 | 2006-07-27 | Pulmonx | Pulmonary occlusal stent delivery catheter, loading system and methods of use |
JP5020824B2 (en) * | 2004-11-16 | 2012-09-05 | ロバート・エル・バリー | Lung therapy apparatus and method |
US7398782B2 (en) | 2004-11-19 | 2008-07-15 | Portaero, Inc. | Method for pulmonary drug delivery |
US11883029B2 (en) | 2005-01-20 | 2024-01-30 | Pulmonx Corporation | Methods and devices for passive residual lung volume reduction and functional lung volume expansion |
US20080228137A1 (en) | 2007-03-12 | 2008-09-18 | Pulmonx | Methods and devices for passive residual lung volume reduction and functional lung volume expansion |
US8496006B2 (en) | 2005-01-20 | 2013-07-30 | Pulmonx Corporation | Methods and devices for passive residual lung volume reduction and functional lung volume expansion |
US20070032785A1 (en) | 2005-08-03 | 2007-02-08 | Jennifer Diederich | Tissue evacuation device |
US8523782B2 (en) | 2005-12-07 | 2013-09-03 | Pulmonx Corporation | Minimally invasive determination of collateral ventilation in lungs |
US7993323B2 (en) | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US8585645B2 (en) * | 2006-11-13 | 2013-11-19 | Uptake Medical Corp. | Treatment with high temperature vapor |
DE102006057809A1 (en) * | 2006-12-06 | 2008-06-12 | Ruprecht-Karls-Universität Heidelberg | intubation tube |
US20080221582A1 (en) * | 2007-03-05 | 2008-09-11 | Pulmonx | Pulmonary stent removal device |
US8100959B2 (en) * | 2007-03-09 | 2012-01-24 | Pulmonx Corporation | Loading device for a pulmonary implant |
US8137302B2 (en) * | 2007-03-12 | 2012-03-20 | Pulmonx Corporation | Methods and systems for occluding collateral flow channels in the lung |
ATE556667T1 (en) | 2007-08-23 | 2012-05-15 | Aegea Medical Inc | UTERUS THERAPY DEVICE |
ES2456965T3 (en) * | 2007-10-22 | 2014-04-24 | Uptake Medical Corp. | Determination of the parameters of the steam treatment and administration specific to the patient |
US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
US9924992B2 (en) | 2008-02-20 | 2018-03-27 | Tsunami Medtech, Llc | Medical system and method of use |
US8721632B2 (en) | 2008-09-09 | 2014-05-13 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US8579888B2 (en) | 2008-06-17 | 2013-11-12 | Tsunami Medtech, Llc | Medical probes for the treatment of blood vessels |
US20100036361A1 (en) * | 2008-06-20 | 2010-02-11 | Pulmonx | System and method for delivering multiple implants into lung passageways |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
CN102238920B (en) | 2008-10-06 | 2015-03-25 | 维兰德.K.沙马 | Method and apparatus for tissue ablation |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
US8468637B2 (en) | 2009-02-06 | 2013-06-25 | Endoclear Llc | Mechanically-actuated endotracheal tube cleaning device |
EP2393538B1 (en) | 2009-02-06 | 2017-10-18 | Endoclear LLC | Devices for cleaning endotracheal tubes |
FR2945954A1 (en) * | 2009-05-27 | 2010-12-03 | Dioptik | Intubation probe for introduction into trachea of patient during anesthesia and nasal intubation, has internal tube inserted into external tube, where surfaces of respective tubes define receiving housing of ducts |
US8900223B2 (en) | 2009-11-06 | 2014-12-02 | Tsunami Medtech, Llc | Tissue ablation systems and methods of use |
US9161801B2 (en) | 2009-12-30 | 2015-10-20 | Tsunami Medtech, Llc | Medical system and method of use |
EP2902066B1 (en) | 2010-03-29 | 2021-03-10 | Endoclear LLC | Airway cleaning and visualization |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
US20120095369A1 (en) | 2010-10-15 | 2012-04-19 | Teixeira Scott M | System and Method for Sampling Device for Bodily Fluids |
US9743974B2 (en) | 2010-11-09 | 2017-08-29 | Aegea Medical Inc. | Positioning method and apparatus for delivering vapor to the uterus |
JP6017568B2 (en) | 2011-10-07 | 2016-11-02 | イージー メディカル, インコーポレーテッド | Uterine treatment device |
WO2013063520A1 (en) | 2011-10-27 | 2013-05-02 | Endoclear, Llc | Endotracheal tube coupling adapters |
EP2903514B1 (en) * | 2012-10-02 | 2022-11-23 | Lutz Freitag | Systems for pulmonary diagnosis |
EP2928517B1 (en) | 2012-12-04 | 2021-02-17 | Endoclear LLC | Suction cleaning devices |
EP2945556A4 (en) | 2013-01-17 | 2016-08-31 | Virender K Sharma | Method and apparatus for tissue ablation |
US9434977B2 (en) | 2013-02-27 | 2016-09-06 | Avent, Inc. | Rapid identification of organisms in bodily fluids |
US8668654B1 (en) | 2013-03-13 | 2014-03-11 | Sanovas, Inc. | Cytological brushing system |
US9782211B2 (en) | 2013-10-01 | 2017-10-10 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
US9101391B2 (en) | 2013-11-11 | 2015-08-11 | Cross Bay Medical, Inc. | Apparatus and methods for accessing and sealing bodily vessels and cavities |
US10034986B2 (en) * | 2013-11-11 | 2018-07-31 | Crossbay Medical, Inc. | Method and apparatus of tubal patency catheter and delivery systems |
US10245074B2 (en) | 2013-11-11 | 2019-04-02 | Crossbay Medical, Inc. | Apparatus and methods for accessing and sealing bodily vessels and cavities |
WO2015112835A1 (en) | 2014-01-24 | 2015-07-30 | COLE Research & Design, Inc. | Oral suction device |
US9993290B2 (en) | 2014-05-22 | 2018-06-12 | Aegea Medical Inc. | Systems and methods for performing endometrial ablation |
US10179019B2 (en) | 2014-05-22 | 2019-01-15 | Aegea Medical Inc. | Integrity testing method and apparatus for delivering vapor to the uterus |
EP3151898B1 (en) | 2014-06-03 | 2021-03-24 | Endoclear LLC | Cleaning devices, systems and methods |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
US20160331343A1 (en) | 2015-05-11 | 2016-11-17 | Veran Medical Technologies, Inc. | Medical apparatus with translatable imaging device for real-time confirmation of interception of target tissue |
ITUB20160135A1 (en) * | 2016-01-15 | 2017-07-15 | Angiodroid S R L A Socio Unico | ANGIOGRAPHIC INTRODUCTION DEVICE WITH OCCLUSIVE BALL FOR COMPLEX ENDOVASCULAR INTERVENTIONS |
US11331037B2 (en) | 2016-02-19 | 2022-05-17 | Aegea Medical Inc. | Methods and apparatus for determining the integrity of a bodily cavity |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US11419490B2 (en) * | 2016-08-02 | 2022-08-23 | Covidien Lp | System and method of using an endoscopic catheter as a port in laparoscopic surgery |
US10448886B2 (en) | 2016-08-17 | 2019-10-22 | Covidien Lp | Induced atelectasis and pulmonary consolidation systems and methods |
US10799092B2 (en) | 2016-09-19 | 2020-10-13 | Covidien Lp | System and method for cleansing segments of a luminal network |
CN109789297A (en) | 2016-09-30 | 2019-05-21 | 纽姆克斯股份有限公司 | Seal wire |
US11510646B2 (en) * | 2017-04-05 | 2022-11-29 | Bk Medical Aps | Ultrasound imaging system probe cable and connector |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
US11141308B2 (en) | 2017-08-31 | 2021-10-12 | Crossbay Medical, Inc. | Apparatus and method for everting catheter for IUD delivery and placement in the uterine cavity |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
CN107802946A (en) * | 2017-11-13 | 2018-03-16 | 北京大学第医院 | A kind of bronchoscope foley's tube component |
US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
JP2021525598A (en) | 2018-06-01 | 2021-09-27 | サンタ アナ テック エルエルシーSanta Anna Tech Llc | Multi-stage steam-based ablation processing method and steam generation and delivery system |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
CN109847139B (en) * | 2019-03-07 | 2020-01-14 | 谢晴晴 | Intelligent lung breathing lavage device |
US11717656B2 (en) * | 2019-03-20 | 2023-08-08 | Gyros ACMI Inc. | Delivery of mixed phase media for the treatment of the anatomy |
CN112843436A (en) * | 2020-02-16 | 2021-05-28 | 东莞天天向上医疗科技有限公司 | Multifunctional balloon dilatation catheter for in vivo pulmonary membrane oxygenation and use method |
WO2021219659A1 (en) * | 2020-04-28 | 2021-11-04 | Carag Ag | Device for treating lung diseases |
EP3932457A1 (en) * | 2020-07-02 | 2022-01-05 | Carag AG | Tracheal catheter, intubation hose and treatment device |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6010740B2 (en) | 1981-05-07 | 1985-03-19 | 宏司 井上 | Endotracheal tube for unilateral lung ventilation |
US4714460A (en) * | 1983-07-29 | 1987-12-22 | Reynaldo Calderon | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency |
US4716896A (en) | 1986-08-01 | 1988-01-05 | Ackrad Laboratories | Bronchial catheter |
US5207220A (en) | 1989-12-12 | 1993-05-04 | Burroughs Wellcome Co. | Method for administering pharmaceuticals, including liquid surfactant, to the lungs |
US5246012A (en) | 1990-12-21 | 1993-09-21 | Ballard Medical Products | Bronchoalveolar lavage catheter |
US5285778A (en) | 1991-04-19 | 1994-02-15 | Mackin Robert A | Endotracheal tube wih fibers optic illumination and viewing and auxiliary tube |
US5660175A (en) | 1995-08-21 | 1997-08-26 | Dayal; Bimal | Endotracheal device |
US5653231A (en) | 1995-11-28 | 1997-08-05 | Medcare Medical Group, Inc. | Tracheostomy length single use suction catheter |
-
1999
- 1999-10-21 US US09/425,272 patent/US6398775B1/en not_active Expired - Lifetime
-
2000
- 2000-10-24 WO PCT/US2000/029417 patent/WO2003105941A1/en active Application Filing
-
2002
- 2002-02-11 US US10/074,861 patent/US20020077593A1/en not_active Abandoned
Cited By (343)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070005083A1 (en) * | 1997-04-30 | 2007-01-04 | Sabaratham Sabanathan | Occlusion device |
US7670373B1 (en) | 1997-04-30 | 2010-03-02 | Pulmonx Corporation | Occlusion device |
US8136520B2 (en) | 1997-04-30 | 2012-03-20 | Pulmonx Corporation | Occlusion device |
US20030212452A1 (en) * | 1997-09-16 | 2003-11-13 | Gholam-Reza Zadno-Azizi | Body fluid flow control device |
US20020095209A1 (en) * | 1997-09-16 | 2002-07-18 | Gholam-Reza Zadno-Azizi | Body fluid flow control device |
US20030199972A1 (en) * | 1997-09-16 | 2003-10-23 | Gholam-Reza Zadno-Azizi | Body fluid flow control device |
US20040078054A1 (en) * | 1998-06-05 | 2004-04-22 | Broncus Technologies, Inc. | Method for lung volume reduction |
US6997189B2 (en) | 1998-06-05 | 2006-02-14 | Broncus Technologies, Inc. | Method for lung volume reduction |
US20110226238A1 (en) * | 2000-03-04 | 2011-09-22 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
US8474460B2 (en) | 2000-03-04 | 2013-07-02 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
US20060174870A1 (en) * | 2000-03-04 | 2006-08-10 | Deem Mark E | Methods and devices for use in performing pulmonary procedures |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US8357139B2 (en) | 2000-03-04 | 2013-01-22 | Pulmonx Corporation | Methods and devices for use in performing pulmonary procedures |
US6694979B2 (en) | 2000-03-04 | 2004-02-24 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US7662181B2 (en) | 2000-03-04 | 2010-02-16 | Pulmonx Corporation | Methods and devices for use in performing pulmonary procedures |
US20050051163A1 (en) * | 2000-03-04 | 2005-03-10 | Deem Mark E. | Methods and devices for use in performing pulmonary procedures |
US20040134487A1 (en) * | 2000-03-04 | 2004-07-15 | Deem Mark E. | Methods and devices for use in performing pulmonary procedures |
US7334581B2 (en) | 2000-06-16 | 2008-02-26 | Ventus Medical, Inc. | Methods and devices for improving breathing in patients with pulmonary disease |
US8707955B2 (en) | 2000-06-16 | 2014-04-29 | Theravent, Inc. | Methods and devices for improving breathing in patients with pulmonary disease |
US6722360B2 (en) | 2000-06-16 | 2004-04-20 | Rajiv Doshi | Methods and devices for improving breathing in patients with pulmonary disease |
US20060032497A1 (en) * | 2000-06-16 | 2006-02-16 | Rajiv Doshi | Methods and devices for improving breathing in patients with pulmonary disease |
US20080173309A1 (en) * | 2000-06-16 | 2008-07-24 | Rajiv Doshi | Methods and devices for improving breathing in patients with pulmonary disease |
US7992563B2 (en) | 2000-06-16 | 2011-08-09 | Ventus Medical, Inc. | Methods and devices for improving breathing in patients with pulmonary disease |
US20020112729A1 (en) * | 2001-02-21 | 2002-08-22 | Spiration, Inc. | Intra-bronchial obstructing device that controls biological interaction with the patient |
US20110017207A1 (en) * | 2001-03-02 | 2011-01-27 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US8251067B2 (en) | 2001-03-02 | 2012-08-28 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US7798147B2 (en) | 2001-03-02 | 2010-09-21 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US20040074491A1 (en) * | 2001-03-02 | 2004-04-22 | Michael Hendricksen | Delivery methods and devices for implantable bronchial isolation devices |
US20040060563A1 (en) * | 2001-03-02 | 2004-04-01 | Alan Rapacki | Bronchial flow control devices and methods of use |
US20040055606A1 (en) * | 2001-03-02 | 2004-03-25 | Emphasys Medical, Inc. | Bronchial flow control devices with membrane seal |
US20040211412A1 (en) * | 2001-09-11 | 2004-10-28 | Alferness Clifton A. | Removable lung reduction devices, systems, and method |
US7757692B2 (en) | 2001-09-11 | 2010-07-20 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US20040206349A1 (en) * | 2001-09-11 | 2004-10-21 | Alferness Clifton A. | Removable lung reduction devices, systems, and methods |
US8414655B2 (en) | 2001-09-11 | 2013-04-09 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US8974484B2 (en) | 2001-09-11 | 2015-03-10 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US20030070682A1 (en) * | 2001-10-11 | 2003-04-17 | Wilson Peter M. | Bronchial flow control devices and methods of use |
US7854228B2 (en) | 2001-10-11 | 2010-12-21 | Pulmonx Corporation | Bronchial flow control devices and methods of use |
US20050166925A1 (en) * | 2001-10-11 | 2005-08-04 | Emphasys Medical, Inc., A California Corporation | Bronchial flow control devices and methods of use |
US20050145253A1 (en) * | 2001-10-11 | 2005-07-07 | Emphasys Medical, Inc., A Delaware Corporation | Bronchial flow control devices and methods of use |
US20030183235A1 (en) * | 2001-10-25 | 2003-10-02 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
US20070185531A1 (en) * | 2001-10-25 | 2007-08-09 | Spiration, Inc. | Apparatus and method for deployment of a bronchial obstruction device |
US8986336B2 (en) | 2001-10-25 | 2015-03-24 | Spiration, Inc. | Apparatus and method for deployment of a bronchial obstruction device |
US7896887B2 (en) | 2001-10-25 | 2011-03-01 | Spiration, Inc. | Apparatus and method for deployment of a bronchial obstruction device |
US20030158515A1 (en) * | 2002-02-21 | 2003-08-21 | Spiration, Inc. | Device and method for intra-bronchial provision of a therapeutic agent |
US20060235432A1 (en) * | 2002-02-21 | 2006-10-19 | Devore Lauri J | Intra-bronchial obstructing device that controls biological interaction with the patient |
US20060206147A1 (en) * | 2002-02-21 | 2006-09-14 | Devore Lauri J | Intra-bronchial obstruction device that provides a medicant intra-bronchially to the patient |
US20060200076A1 (en) * | 2002-02-21 | 2006-09-07 | Gonzalez Hugo X | Device and method for intra-bronchial provision of a therapeutic agent |
US7942931B2 (en) | 2002-02-21 | 2011-05-17 | Spiration, Inc. | Device and method for intra-bronchial provision of a therapeutic agent |
US20060283462A1 (en) * | 2002-03-08 | 2006-12-21 | Fields Antony J | Methods and devices for inducing collapse in lung regions fed by collateral pathways |
US20080249503A1 (en) * | 2002-03-08 | 2008-10-09 | Fields Antony J | Methods and devices for lung treatment |
US20030228344A1 (en) * | 2002-03-08 | 2003-12-11 | Fields Antony J. | Methods and devices for inducing collapse in lung regions fed by collateral pathways |
US8021385B2 (en) | 2002-03-20 | 2011-09-20 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US8177805B2 (en) | 2002-03-20 | 2012-05-15 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US8926647B2 (en) | 2002-03-20 | 2015-01-06 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US20060235467A1 (en) * | 2002-04-16 | 2006-10-19 | Devore Lauri J | Removable anchored lung volume reduction device and methods |
US20030195385A1 (en) * | 2002-04-16 | 2003-10-16 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US20030212412A1 (en) * | 2002-05-09 | 2003-11-13 | Spiration, Inc. | Intra-bronchial obstructing device that permits mucus transport |
US20030216769A1 (en) * | 2002-05-17 | 2003-11-20 | Dillard David H. | Removable anchored lung volume reduction devices and methods |
US7875048B2 (en) | 2002-05-17 | 2011-01-25 | Spiration, Inc. | One-way valve devices for anchored implantation in a lung |
US7842061B2 (en) | 2002-05-17 | 2010-11-30 | Spiration, Inc. | Methods of achieving lung volume reduction with removable anchored devices |
US8257381B2 (en) | 2002-05-17 | 2012-09-04 | Spiration, Inc. | One-way valve devices for anchored implantation in a lung |
US8956319B2 (en) | 2002-05-17 | 2015-02-17 | Spiration, Inc. | One-way valve devices for anchored implantation in a lung |
US20050033344A1 (en) * | 2002-05-17 | 2005-02-10 | Dillard David H. | One-way valve devices for anchored implantation in a lung |
US20050066974A1 (en) * | 2002-05-28 | 2005-03-31 | Antony Fields | Modification of lung region flow dynamics using flow control devices implanted in bronchial wall channels |
US20040039250A1 (en) * | 2002-05-28 | 2004-02-26 | David Tholfsen | Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment |
US20060076023A1 (en) * | 2002-07-26 | 2006-04-13 | Emphasys Medical, Inc., A Delaware Corporation | Bronchial flow control devices and methods of use |
EP1386635A1 (en) * | 2002-07-31 | 2004-02-04 | Cordis Corporation | Long term oxygen therapy system |
US7086398B2 (en) | 2002-07-31 | 2006-08-08 | Cordis Corporation | Long term oxygen therapy system |
US7814912B2 (en) | 2002-11-27 | 2010-10-19 | Pulmonx Corporation | Delivery methods and devices for implantable bronchial isolation devices |
US20040148035A1 (en) * | 2002-11-27 | 2004-07-29 | Michael Barrett | Delivery methods and devices for implantable bronchial isolation devices |
US20060004305A1 (en) * | 2002-11-27 | 2006-01-05 | George Robert M | Delivery methods and devices for implantable bronchial isolation devices |
US7717115B2 (en) | 2002-11-27 | 2010-05-18 | Pulmonx Corporation | Delivery methods and devices for implantable bronchial isolation devices |
WO2004064885A3 (en) * | 2003-01-20 | 2004-10-21 | Pulmonx | Methods and arrangement for reducing the volume of the lung |
US20050061322A1 (en) * | 2003-01-20 | 2005-03-24 | Pulmonx | Method and arrangement for reducing the volume of a lung |
US20040210248A1 (en) * | 2003-03-12 | 2004-10-21 | Spiration, Inc. | Apparatus, method and assembly for delivery of intra-bronchial devices |
US8667973B2 (en) | 2003-04-08 | 2014-03-11 | Spiration, Inc. | Bronchoscopic lung volume reduction method |
US20060249164A1 (en) * | 2003-04-08 | 2006-11-09 | Springmeyer Steven C | Bronchoscopic lung volume reduction method |
US8079368B2 (en) | 2003-04-08 | 2011-12-20 | Spiration, Inc. | Bronchoscopic lung volume reduction method |
US20040200484A1 (en) * | 2003-04-08 | 2004-10-14 | Springmeyer Steven C. | Bronchoscopic lung volume reduction method |
US8029492B2 (en) | 2003-05-07 | 2011-10-04 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7828789B2 (en) | 2003-05-07 | 2010-11-09 | Portaero, Inc. | Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis |
US7811274B2 (en) | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US20050203400A1 (en) * | 2003-05-10 | 2005-09-15 | Zappala Stephen M. | System and method for precisely identifying a configuration of an anatomical space in real time |
US7615005B2 (en) | 2003-05-16 | 2009-11-10 | Ethicon Endo-Surgery, Inc. | Medical apparatus for use with an endoscope |
US7789083B2 (en) | 2003-05-20 | 2010-09-07 | Portaero, Inc. | Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease |
US20040243393A1 (en) * | 2003-05-29 | 2004-12-02 | Microsoft Corporation | Semantic object synchronous understanding implemented with speech application language tags |
US7896008B2 (en) | 2003-06-03 | 2011-03-01 | Portaero, Inc. | Lung reduction system |
US7753052B2 (en) | 2003-06-05 | 2010-07-13 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system |
US8323230B2 (en) | 2003-07-15 | 2012-12-04 | Portaero, Inc. | Methods and devices to accelerate wound healing in thoracic anastomosis applications |
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US7887585B2 (en) | 2003-08-08 | 2011-02-15 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US8974527B2 (en) | 2003-08-08 | 2015-03-10 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US8444690B2 (en) | 2003-08-08 | 2013-05-21 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US9622752B2 (en) | 2003-08-08 | 2017-04-18 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US20090182369A1 (en) * | 2003-08-08 | 2009-07-16 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US20110208228A1 (en) * | 2003-08-08 | 2011-08-25 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US20050137714A1 (en) * | 2003-08-08 | 2005-06-23 | Gonzalez Hugo X. | Bronchoscopic repair of air leaks in a lung |
US20090255537A1 (en) * | 2004-01-27 | 2009-10-15 | Pulmonx | Disease indications for selective endobronchial lung region isolation |
US20050178389A1 (en) * | 2004-01-27 | 2005-08-18 | Shaw David P. | Disease indications for selective endobronchial lung region isolation |
US20050196344A1 (en) * | 2004-02-27 | 2005-09-08 | Mccutcheon John | Methods and devices for blocking flow through collateral pathways in the lung |
US8206684B2 (en) | 2004-02-27 | 2012-06-26 | Pulmonx Corporation | Methods and devices for blocking flow through collateral pathways in the lung |
US7585276B2 (en) * | 2004-03-01 | 2009-09-08 | Fujinon Corporation | Endoscope system and operation method for endoscope |
US20090287051A1 (en) * | 2004-03-01 | 2009-11-19 | Fujinon Corporation | Endoscope system and operation method for endoscope |
US20050222500A1 (en) * | 2004-03-01 | 2005-10-06 | Fujinon Corporation | Endoscope system and operation method for endoscope |
US20060020347A1 (en) * | 2004-03-08 | 2006-01-26 | Michael Barrett | Implanted bronchial isolation devices and methods |
US9107574B2 (en) | 2004-04-21 | 2015-08-18 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9101384B2 (en) | 2004-04-21 | 2015-08-11 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat |
US8894614B2 (en) | 2004-04-21 | 2014-11-25 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
US8932276B1 (en) | 2004-04-21 | 2015-01-13 | Acclarent, Inc. | Shapeable guide catheters and related methods |
US20100042046A1 (en) * | 2004-04-21 | 2010-02-18 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US8870893B2 (en) | 2004-04-21 | 2014-10-28 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
US8864787B2 (en) | 2004-04-21 | 2014-10-21 | Acclarent, Inc. | Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis |
US8858586B2 (en) | 2004-04-21 | 2014-10-14 | Acclarent, Inc. | Methods for enlarging ostia of paranasal sinuses |
US8852143B2 (en) | 2004-04-21 | 2014-10-07 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
US8828041B2 (en) | 2004-04-21 | 2014-09-09 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US11864725B2 (en) | 2004-04-21 | 2024-01-09 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
US11589742B2 (en) | 2004-04-21 | 2023-02-28 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US8777926B2 (en) | 2004-04-21 | 2014-07-15 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasel or paranasal structures |
US8764726B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US11529502B2 (en) | 2004-04-21 | 2022-12-20 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US11511090B2 (en) | 2004-04-21 | 2022-11-29 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US8764729B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Frontal sinus spacer |
US11202644B2 (en) | 2004-04-21 | 2021-12-21 | Acclarent, Inc. | Shapeable guide catheters and related methods |
US11957318B2 (en) | 2004-04-21 | 2024-04-16 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US8961398B2 (en) * | 2004-04-21 | 2015-02-24 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear, nose and throat |
US8764709B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
US8747389B2 (en) | 2004-04-21 | 2014-06-10 | Acclarent, Inc. | Systems for treating disorders of the ear, nose and throat |
US11065061B2 (en) | 2004-04-21 | 2021-07-20 | Acclarent, Inc. | Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses |
US8961495B2 (en) | 2004-04-21 | 2015-02-24 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
US11019989B2 (en) | 2004-04-21 | 2021-06-01 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US20080287908A1 (en) * | 2004-04-21 | 2008-11-20 | Acclarent, Inc. | Ethmoidotomy System and Implantable Spacer Devices Having Therapeutic Substance Delivery Capability for Treatment of Paranasal Sinusitis |
US11020136B2 (en) | 2004-04-21 | 2021-06-01 | Acclarent, Inc. | Deflectable guide catheters and related methods |
US20110060214A1 (en) * | 2004-04-21 | 2011-03-10 | Acclarent, Inc. | Systems and Methods for Performing Image Guided Procedures Within the Ear, Nose, Throat and Paranasal Sinuses |
US8721591B2 (en) | 2004-04-21 | 2014-05-13 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US10874838B2 (en) | 2004-04-21 | 2020-12-29 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US10856727B2 (en) | 2004-04-21 | 2020-12-08 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US8715169B2 (en) | 2004-04-21 | 2014-05-06 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US20110112512A1 (en) * | 2004-04-21 | 2011-05-12 | Acclarent, Inc. | Devices and methods for treating maxillary sinus disease |
US20080132938A1 (en) * | 2004-04-21 | 2008-06-05 | Acclarent, Inc. | Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat |
US10806477B2 (en) | 2004-04-21 | 2020-10-20 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US10779752B2 (en) | 2004-04-21 | 2020-09-22 | Acclarent, Inc. | Guidewires for performing image guided procedures |
US20080125626A1 (en) * | 2004-04-21 | 2008-05-29 | Acclarent, Inc. | Devices, Systems and Methods Useable for Treating Sinusitis |
US8702626B1 (en) | 2004-04-21 | 2014-04-22 | Acclarent, Inc. | Guidewires for performing image guided procedures |
US20080119693A1 (en) * | 2004-04-21 | 2008-05-22 | Acclarent, Inc. | Methods and Apparatus for Treating Disorders of the Ear, Nose and Throat |
US10702295B2 (en) | 2004-04-21 | 2020-07-07 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US10695080B2 (en) | 2004-04-21 | 2020-06-30 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
US10631756B2 (en) | 2004-04-21 | 2020-04-28 | Acclarent, Inc. | Guidewires for performing image guided procedures |
US9055965B2 (en) | 2004-04-21 | 2015-06-16 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US20070293727A1 (en) * | 2004-04-21 | 2007-12-20 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9089258B2 (en) | 2004-04-21 | 2015-07-28 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US8905922B2 (en) | 2004-04-21 | 2014-12-09 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
US9167961B2 (en) | 2004-04-21 | 2015-10-27 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US10500380B2 (en) | 2004-04-21 | 2019-12-10 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US10492810B2 (en) | 2004-04-21 | 2019-12-03 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
US9220879B2 (en) | 2004-04-21 | 2015-12-29 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US10188413B1 (en) | 2004-04-21 | 2019-01-29 | Acclarent, Inc. | Deflectable guide catheters and related methods |
US9241834B2 (en) | 2004-04-21 | 2016-01-26 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
US10098652B2 (en) | 2004-04-21 | 2018-10-16 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US10034682B2 (en) | 2004-04-21 | 2018-07-31 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
US9265407B2 (en) | 2004-04-21 | 2016-02-23 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9649477B2 (en) | 2004-04-21 | 2017-05-16 | Acclarent, Inc. | Frontal sinus spacer |
US9351750B2 (en) | 2004-04-21 | 2016-05-31 | Acclarent, Inc. | Devices and methods for treating maxillary sinus disease |
US9826999B2 (en) | 2004-04-21 | 2017-11-28 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US9370649B2 (en) | 2004-04-21 | 2016-06-21 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US9399121B2 (en) | 2004-04-21 | 2016-07-26 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US9468362B2 (en) | 2004-04-21 | 2016-10-18 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US10441758B2 (en) | 2004-04-21 | 2019-10-15 | Acclarent, Inc. | Frontal sinus spacer |
US9554691B2 (en) | 2004-04-21 | 2017-01-31 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9814379B2 (en) | 2004-04-21 | 2017-11-14 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US9610428B2 (en) | 2004-04-21 | 2017-04-04 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
US7775968B2 (en) | 2004-06-14 | 2010-08-17 | Pneumrx, Inc. | Guided access to lung tissues |
US7670282B2 (en) | 2004-06-14 | 2010-03-02 | Pneumrx, Inc. | Lung access device |
US20060009748A1 (en) * | 2004-06-16 | 2006-01-12 | Mathis Mark L | Method of compressing a portion of a lung |
US7766938B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US20060030863A1 (en) * | 2004-07-21 | 2006-02-09 | Fields Antony J | Implanted bronchial isolation device delivery devices and methods |
US7013899B2 (en) | 2004-08-13 | 2006-03-21 | Engineered Medical System, Inc. | Perilaryngeal oral airway with multi-lumen esophogeal-obturator |
US20060032505A1 (en) * | 2004-08-13 | 2006-02-16 | Engineered Medical Systems, Inc. | Perilaryngeal oral airway with multi-lumen esophogeal-obturator |
US7771472B2 (en) | 2004-11-19 | 2010-08-10 | Pulmonx Corporation | Bronchial flow control devices and methods of use |
US11083556B2 (en) | 2004-11-19 | 2021-08-10 | Pulmonx Corporation | Implant loading device and system |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US12064331B2 (en) | 2004-11-19 | 2024-08-20 | Pulmonx Corporation | Implant loading device and system |
US8388682B2 (en) | 2004-11-19 | 2013-03-05 | Pulmonx Corporation | Bronchial flow control devices and methods of use |
US9872755B2 (en) | 2004-11-19 | 2018-01-23 | Pulmonx Corporation | Implant loading device and system |
US9211181B2 (en) | 2004-11-19 | 2015-12-15 | Pulmonx Corporation | Implant loading device and system |
US10034999B2 (en) | 2004-11-23 | 2018-07-31 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US9125639B2 (en) | 2004-11-23 | 2015-09-08 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US20060150978A1 (en) * | 2004-12-08 | 2006-07-13 | Ventus Medical, Inc. | Methods of treating respiratory disorders |
US8291909B2 (en) | 2004-12-08 | 2012-10-23 | Ventus Medical, Inc. | Methods of treating a disorder by inhibiting expiration |
US7735491B2 (en) | 2004-12-08 | 2010-06-15 | Ventus Medical, Inc. | Methods of treating respiratory disorders |
US9238113B2 (en) | 2004-12-08 | 2016-01-19 | Theravent, Inc. | Nasal respiratory devices for positive end-expiratory pressure |
US8235046B2 (en) | 2004-12-08 | 2012-08-07 | Ventus Medical, Inc. | Nasal devices for use while sleeping |
US20090050144A1 (en) * | 2004-12-08 | 2009-02-26 | Ryan Kendall Pierce | Adhesive nasal respiratory devices |
US7735492B2 (en) | 2004-12-08 | 2010-06-15 | Ventus Medical, Inc. | Nasal respiratory devices |
US8061357B2 (en) | 2004-12-08 | 2011-11-22 | Ventus Medical, Inc. | Adhesive nasal respiratory devices |
US9833354B2 (en) | 2004-12-08 | 2017-12-05 | Theravent, Inc. | Nasal respiratory devices |
US7806120B2 (en) | 2004-12-08 | 2010-10-05 | Ventus Medical, Inc. | Nasal respiratory devices for positive end-expiratory pressure |
US20060150979A1 (en) * | 2004-12-08 | 2006-07-13 | Ventus Medical, Inc. | Nasal respiratory devices |
US8215308B2 (en) | 2004-12-08 | 2012-07-10 | Ventus Medical, Inc. | Sealing nasal devices for use while sleeping |
US20100147308A1 (en) * | 2004-12-08 | 2010-06-17 | Rajiv Doshi | Respiratory devices |
US20060144398A1 (en) * | 2004-12-08 | 2006-07-06 | Rajiv Doshi | Respiratory devices |
US8365736B2 (en) | 2004-12-08 | 2013-02-05 | Ventus Medical, Inc. | Nasal devices with respiratory gas source |
US10610228B2 (en) | 2004-12-08 | 2020-04-07 | Theravent, Inc. | Passive nasal peep devices |
US8302606B2 (en) | 2004-12-08 | 2012-11-06 | Ventus Medical, Inc. | Methods of treating a sleeping subject |
US7992564B2 (en) | 2004-12-08 | 2011-08-09 | Ventus Medical, Inc. | Respiratory devices |
US7798148B2 (en) | 2004-12-08 | 2010-09-21 | Ventus Medical, Inc. | Respiratory devices |
US8302607B2 (en) | 2004-12-08 | 2012-11-06 | Ventus Medical, Inc. | Adhesive nasal respiratory devices |
EP1669095A1 (en) | 2004-12-10 | 2006-06-14 | Nitinol Development Corporation | Collateral ventilation device with chest tube/evacuation features |
US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US9308361B2 (en) | 2005-01-18 | 2016-04-12 | Acclarent, Inc. | Implantable devices and methods for treating sinusitis and other disorders |
US8876791B2 (en) | 2005-02-25 | 2014-11-04 | Pulmonx Corporation | Collateral pathway treatment using agent entrained by aspiration flow current |
US20060258907A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Track for medical devices |
US20060258903A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Method of inserting a feeding tube |
US7857754B2 (en) * | 2005-05-13 | 2010-12-28 | Ethicon Endo-Surgery, Inc. | Apparatus useful for positioning a device on an endoscope |
US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
US7905830B2 (en) | 2005-05-13 | 2011-03-15 | Ethicon Endo-Surgery, Inc. | Sheath for use with an endoscope |
US20060258902A1 (en) * | 2005-05-13 | 2006-11-16 | Spivey James T | Apparatus useful for positioning a device on an endoscope |
EP1888156A2 (en) * | 2005-05-13 | 2008-02-20 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US10561527B2 (en) * | 2005-05-13 | 2020-02-18 | Braincool Ab | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
EP1888156A4 (en) * | 2005-05-13 | 2014-04-09 | Benechill Inc | Methods and devices for non-invasive cerebral and systemic cooling |
US20060258904A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Feeding tube and track |
US7615003B2 (en) | 2005-05-13 | 2009-11-10 | Ethicon Endo-Surgery, Inc. | Track for medical devices |
US7648457B2 (en) | 2005-05-13 | 2010-01-19 | Ethicon Endo-Surgery, Inc. | Method of positioning a device on an endoscope |
US20060258910A1 (en) * | 2005-05-13 | 2006-11-16 | David Stefanchik | Method of positioning a device on an endoscope |
US8951225B2 (en) | 2005-06-10 | 2015-02-10 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
US10842978B2 (en) | 2005-06-10 | 2020-11-24 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
US10124154B2 (en) | 2005-06-10 | 2018-11-13 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
EP1757322A1 (en) * | 2005-08-23 | 2007-02-28 | Nitinol Development Corporation | Collateral ventilation bypass system with retention features |
US8104474B2 (en) * | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US20070063687A1 (en) * | 2005-09-20 | 2007-03-22 | Dacheng Zhou | Circuit and method for bias voltage generation |
US7726305B2 (en) | 2006-01-17 | 2010-06-01 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7686013B2 (en) | 2006-01-17 | 2010-03-30 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US8157823B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US9402971B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Minimally invasive lung volume reduction devices, methods, and systems |
US9782558B2 (en) | 2006-03-13 | 2017-10-10 | Pneumrx, Inc. | Minimally invasive lung volume reduction devices, methods, and systems |
US8740921B2 (en) | 2006-03-13 | 2014-06-03 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8282660B2 (en) | 2006-03-13 | 2012-10-09 | Pneumrx, Inc. | Minimally invasive lung volume reduction devices, methods, and systems |
US9474533B2 (en) | 2006-03-13 | 2016-10-25 | Pneumrx, Inc. | Cross-sectional modification during deployment of an elongate lung volume reduction device |
US8668707B2 (en) | 2006-03-13 | 2014-03-11 | Pneumrx, Inc. | Minimally invasive lung volume reduction devices, methods, and systems |
US8932310B2 (en) | 2006-03-13 | 2015-01-13 | Pneumrx, Inc. | Minimally invasive lung volume reduction devices, methods, and systems |
US10226257B2 (en) | 2006-03-13 | 2019-03-12 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US9402632B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US10188397B2 (en) | 2006-03-13 | 2019-01-29 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US8142455B2 (en) | 2006-03-13 | 2012-03-27 | Pneumrx, Inc. | Delivery of minimally invasive lung volume reduction devices |
US20070232992A1 (en) * | 2006-03-31 | 2007-10-04 | James Kutsko | Articulable anchor |
US7691151B2 (en) | 2006-03-31 | 2010-04-06 | Spiration, Inc. | Articulable Anchor |
US9198669B2 (en) | 2006-03-31 | 2015-12-01 | Spiration, Inc. | Articulable anchor |
US8647392B2 (en) | 2006-03-31 | 2014-02-11 | Spiration, Inc. | Articulable anchor |
US8454708B2 (en) | 2006-03-31 | 2013-06-04 | Spiration, Inc. | Articulable anchor |
US20070235846A1 (en) * | 2006-04-01 | 2007-10-11 | Stats Chippac Ltd. | Integrated circuit package system with net spacer |
US7856979B2 (en) | 2006-05-23 | 2010-12-28 | Ventus Medical, Inc. | Nasal respiratory devices |
US8985116B2 (en) | 2006-06-07 | 2015-03-24 | Theravent, Inc. | Layered nasal devices |
US7987852B2 (en) | 2006-06-07 | 2011-08-02 | Ventus Medical, Inc. | Nasal devices |
US20080041373A1 (en) * | 2006-06-07 | 2008-02-21 | Ventus Medical, Inc. | Nasal devices |
US10639452B2 (en) | 2006-07-13 | 2020-05-05 | Best Medical International, Inc. | Echo-opaque urethral catheter |
US9820688B2 (en) | 2006-09-15 | 2017-11-21 | Acclarent, Inc. | Sinus illumination lightwire device |
US9603506B2 (en) | 2006-09-15 | 2017-03-28 | Acclarent, Inc. | Methods and devices for facilitating visualization in a surgical environment |
US9572480B2 (en) | 2006-09-15 | 2017-02-21 | Acclarent, Inc. | Methods and devices for facilitating visualization in a surgical environment |
US10716629B2 (en) | 2006-09-15 | 2020-07-21 | Acclarent, Inc. | Methods and devices for facilitating visualization in a surgical environment |
US9179823B2 (en) | 2006-09-15 | 2015-11-10 | Acclarent, Inc. | Methods and devices for facilitating visualization in a surgical environment |
US20080178874A1 (en) * | 2006-11-16 | 2008-07-31 | Ventus Medical, Inc. | Adjustable nasal devices |
US8240309B2 (en) | 2006-11-16 | 2012-08-14 | Ventus Medical, Inc. | Adjustable nasal devices |
US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US20080287878A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Pulmonary visceral pleura anastomosis reinforcement |
US8062315B2 (en) * | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8136230B2 (en) | 2007-10-12 | 2012-03-20 | Spiration, Inc. | Valve loader method, system, and apparatus |
US9326873B2 (en) | 2007-10-12 | 2016-05-03 | Spiration, Inc. | Valve loader method, system, and apparatus |
US8043301B2 (en) | 2007-10-12 | 2011-10-25 | Spiration, Inc. | Valve loader method, system, and apparatus |
US8281557B2 (en) | 2007-12-05 | 2012-10-09 | Ventus Medical, Inc. | Method of packaging and dispensing nasal devices |
US8020700B2 (en) | 2007-12-05 | 2011-09-20 | Ventus Medical, Inc. | Packaging and dispensing nasal devices |
US8453637B2 (en) | 2008-02-19 | 2013-06-04 | Portaero, Inc. | Pneumostoma management system for treatment of chronic obstructive pulmonary disease |
US8365722B2 (en) | 2008-02-19 | 2013-02-05 | Portaero, Inc. | Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8491602B2 (en) | 2008-02-19 | 2013-07-23 | Portaero, Inc. | Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease |
US8506577B2 (en) | 2008-02-19 | 2013-08-13 | Portaero, Inc. | Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease |
US8464708B2 (en) | 2008-02-19 | 2013-06-18 | Portaero, Inc. | Pneumostoma management system having a cosmetic and/or protective cover |
US8252003B2 (en) | 2008-02-19 | 2012-08-28 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US8453638B2 (en) | 2008-02-19 | 2013-06-04 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8231581B2 (en) | 2008-02-19 | 2012-07-31 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US20090205651A1 (en) * | 2008-02-19 | 2009-08-20 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8347880B2 (en) | 2008-02-19 | 2013-01-08 | Potaero, Inc. | Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease |
US8021320B2 (en) | 2008-02-19 | 2011-09-20 | Portaero, Inc. | Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma |
US7909803B2 (en) | 2008-02-19 | 2011-03-22 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US8348906B2 (en) | 2008-02-19 | 2013-01-08 | Portaero, Inc. | Aspirator for pneumostoma management |
US8474449B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease |
US8430094B2 (en) | 2008-02-19 | 2013-04-30 | Portaero, Inc. | Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US7927324B2 (en) | 2008-02-19 | 2011-04-19 | Portaero, Inc. | Aspirator and method for pneumostoma management |
US20090301480A1 (en) * | 2008-06-09 | 2009-12-10 | Mamdouh Elsakka | Diagnostic sample collection system and method of use |
WO2009152107A1 (en) * | 2008-06-09 | 2009-12-17 | Allegiance Corporation | Bronchoalveolar lavage catheter assembly |
CN102119039A (en) * | 2008-06-09 | 2011-07-06 | 护理联合2200公司 | Bronchoalveolar lavage catheter assembly |
US20090306545A1 (en) * | 2008-06-09 | 2009-12-10 | Mamdouh Elsakka | Bronchoalveolar lavage catheter assembly |
US20090306544A1 (en) * | 2008-06-09 | 2009-12-10 | Ho-Kin Ng | Instillation/aspiration device |
US20090318757A1 (en) * | 2008-06-23 | 2009-12-24 | Percuvision, Llc | Flexible visually directed medical intubation instrument and method |
US10058331B2 (en) | 2008-09-12 | 2018-08-28 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US10285707B2 (en) | 2008-09-12 | 2019-05-14 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US8632605B2 (en) | 2008-09-12 | 2014-01-21 | Pneumrx, Inc. | Elongated lung volume reduction devices, methods, and systems |
US9173669B2 (en) | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US9192403B2 (en) | 2008-09-12 | 2015-11-24 | Pneumrx, Inc. | Elongated lung volume reduction devices, methods, and systems |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US8721734B2 (en) | 2009-05-18 | 2014-05-13 | Pneumrx, Inc. | Cross-sectional modification during deployment of an elongate lung volume reduction device |
US10076441B2 (en) | 2009-06-19 | 2018-09-18 | Braincool Ab | Devices for cooling the nasal cavity |
US20110251457A1 (en) * | 2010-04-08 | 2011-10-13 | Eric James Kezirian | Endoscopic device and system |
US8764632B2 (en) * | 2010-04-08 | 2014-07-01 | Eric James Kezirian | Endoscopic device and system |
US10064683B2 (en) | 2010-04-08 | 2018-09-04 | Eric James Kezirian | Endoscopic device and system |
US20140350335A1 (en) * | 2010-04-08 | 2014-11-27 | Eric James Kezirian | Endoscopic device and system |
US8875711B2 (en) | 2010-05-27 | 2014-11-04 | Theravent, Inc. | Layered nasal respiratory devices |
US9155492B2 (en) | 2010-09-24 | 2015-10-13 | Acclarent, Inc. | Sinus illumination lightwire device |
US20170311792A1 (en) * | 2010-10-18 | 2017-11-02 | Erhan H. Gunday | Anchored Working Channel |
US8795241B2 (en) | 2011-05-13 | 2014-08-05 | Spiration, Inc. | Deployment catheter |
US10350048B2 (en) | 2011-09-23 | 2019-07-16 | Pulmonx Corporation | Implant loading device and system |
US20140081252A1 (en) * | 2012-09-14 | 2014-03-20 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9949753B2 (en) | 2012-09-14 | 2018-04-24 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9763692B2 (en) | 2012-09-14 | 2017-09-19 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9413896B2 (en) | 2012-09-14 | 2016-08-09 | The Spectranetics Corporation | Tissue slitting methods and systems |
US11596435B2 (en) | 2012-09-14 | 2023-03-07 | Specrtranetics Llc | Tissue slitting methods and systems |
US10531891B2 (en) * | 2012-09-14 | 2020-01-14 | The Spectranetics Corporation | Tissue slitting methods and systems |
US9724122B2 (en) | 2012-09-14 | 2017-08-08 | The Spectranetics Corporation | Expandable lead jacket |
US10368900B2 (en) | 2012-09-14 | 2019-08-06 | The Spectranetics Corporation | Tissue slitting methods and systems |
US10362927B2 (en) * | 2013-02-01 | 2019-07-30 | Deka Products Limited Partnership | Endoscope with pannable camera |
US12075975B2 (en) | 2013-02-01 | 2024-09-03 | Deka Products Limited Partnership | Endoscope with pannable camera |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US11925380B2 (en) | 2013-03-14 | 2024-03-12 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US10349977B2 (en) * | 2013-03-15 | 2019-07-16 | Sanovas Intellectual Property, Llc | Resector balloon catheter with multi-port hub |
US9737195B2 (en) | 2013-03-15 | 2017-08-22 | Sanovas, Inc. | Handheld resector balloon system |
US20140275777A1 (en) * | 2013-03-15 | 2014-09-18 | Erhan H. Gunday | Resector Balloon Catheter With Multi-Port Hub |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
US10624733B2 (en) | 2015-03-24 | 2020-04-21 | Spiration, Inc. | Airway stent |
US20170135560A1 (en) * | 2015-11-18 | 2017-05-18 | Art Healthcare Ltd. | Sheath and hub for imaging endoscope |
US10588493B2 (en) | 2015-11-18 | 2020-03-17 | Art Healthcare Ltd. | Sheath and hub for imaging endoscope |
US10098523B2 (en) * | 2015-11-18 | 2018-10-16 | Art Healthcare Ltd. | Sheath and hub for imaging endoscope |
CN105536081A (en) * | 2016-01-22 | 2016-05-04 | 长江大学 | Full-automatic body cavity effusion and pneumatosis extraction instrument |
US20170258983A1 (en) * | 2016-03-11 | 2017-09-14 | Hans Utz | Illuminated medical infusion |
US10232107B2 (en) * | 2016-03-11 | 2019-03-19 | Hans Utz | Illuminated medical infusion |
US12004707B2 (en) | 2018-04-17 | 2024-06-11 | The Board Of Trustees Of The Leland Stanford Junior University | Airway visualization system |
CN109498966A (en) * | 2019-01-11 | 2019-03-22 | 上海市肺科医院 | Bronchogenic tuberculosis auxiliary therapeutic apparatus under a kind of airway wall |
EP3996789A4 (en) * | 2019-07-12 | 2023-08-23 | Bard Access Systems, Inc. | Tubing with integrated optical fiber, medical devices, and methods thereof |
WO2021011408A1 (en) | 2019-07-12 | 2021-01-21 | Bard Access Systems, Inc. | Tubing with integrated optical fiber, medical devices, and methods thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2003105941A1 (en) | 2003-12-24 |
US6398775B1 (en) | 2002-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6398775B1 (en) | Apparatus and method for isolated lung access | |
US10456519B2 (en) | Apparatus and method for irrigating sinus cavity | |
US7186259B2 (en) | Methods, systems, and kits for lung volume reduction | |
US6585639B1 (en) | Sheath and method for reconfiguring lung viewing scope | |
US6079413A (en) | Catheter system for delivery of aerosolized medicine for use with pressurized propellant canister | |
EP0691866B1 (en) | Balloon catheter and device for perfusion with the balloon catheter | |
KR20080033346A (en) | Multilumen tracheal catheter to prevent cross contamination | |
JPH0663143A (en) | Catheter | |
CN104220015A (en) | Balloon dilation catheter system for treatment and irrigation of the sinuses | |
BRPI0919884B1 (en) | occlusion perfusion catheter | |
WO2001002042A9 (en) | Methods, systems, and kits for lung volume reduction | |
US20210379302A1 (en) | Medical scopes for delivering therapeutic agents | |
US20080228130A1 (en) | Methods and systems for occluding collateral flow channels in the lung | |
JP2000279524A (en) | Catheter | |
US20220355024A1 (en) | Agent delivery devices and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: PULMONX, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PERKINS, RODNEY A.;SOLTESZ, PETER P.;KOTMEL, ROBERT;REEL/FRAME:048642/0638 Effective date: 20000331 |